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ABSTRACT 
 
 
Antigen stimulation of T lymphocytes induces the activation of 
phospholipase D (PLD) signaling. Phospholipase D (PLD) is a 
phosphodiesterase that catalyzes the conversion of phosphatidyl choline (PC) to 
phosphatidic acid (PA). PA is an important lipid second messenger and is known 
to mediate a variety of cellular functions. However, the specific role of PA in T 
lymphocytes has not been established. Previous studies indicated differential 
requirement for TCR induced PLD signaling in regulatory and non-regulatory T 
cells. Inhibition of TCR induced PLD signal preferentially suppressed the growth 
of non-regulatory T cells while allowing the proliferation of regulatory T cells in 
the presence of exogenous IL-2. Based on this observation, we hypothesized 
that PLD signaling is a critical factor that balances the population dynamics 
between regulatory and non-regulatory T cells. 
For my dissertation work, I focused on elucidating the functional and 
molecular regulation of PLD signaling in T cells. In this study, we identified that 
various exogenous (alcohol and Clostridium difficile toxin) and endogenous 
factors (adenosine) modulate PLD signaling altering the population dynamics of 
regulatory and non-regulatory T cells.  
 xvi
  PLD has two isoforms namely PLD1 and PLD2 expressed in mammalian 
cells. These isoforms are 50% identical and have distinct localization in the cell. 
PLD1 has peri-nuclear localization while PLD2 localizes to the plasma 
membrane. Molecular analysis of PLD1 and PLD2 using domain deletion 
suggested that a region unique to PLD1 known as the ‘loop’ confers the distinct 
peri-nuclear localization of PLD1.      
Further, we addressed the specific function of PLD2 in CD4 T cells using 
PLD2 knock out mice. We found that PLD2 is dispensable for T cell activation 
and proliferation but might play an important role in effector T cell differentiation.  
The results from this study delineate some of the functions of PLD signaling in T 
cells and provide insight into immunological regulation during T cell activation. 
 1
INTRODUCTION 
The mammalian immune system exists in a state of equilibrium that allows 
for immune activation (reactivity) against pathogens (foreign antigens) while 
maintaining tolerance (non-reactivity) towards self-antigens. This balance is 
achieved primarily through interactions between different subsets of T 
lymphocytes (Littman and Rudensky, 2010). T cell receptors (TCR) recognize 
short peptides derived from both self and foreign antigens in the context of major 
histocompatibility complex (MHC) thus underscoring their role in both host 
defense and autoimmunity (Sette et al., 1993). The fate of a T cell following 
antigen recognition is influenced by the environmental cues it receives from the 
surrounding milieu like the presence of different cytokines. Through the activation 
of specific transcription factors, various cytokines promote distinct effector T cell 
lineage commitment (Th1, Th2, Th17) thus conferring protection against a wide 
variety of pathogens (Bettelli et al., 2007; Delgoffe et al., 2009). To avoid 
uncontrolled immune activation against foreign and host molecules causing harm 
to the host, the immune system employs various tolerance mechanisms. 
Regulatory T cell mediated immune suppression plays a major role in regulating 
immune response by effector T cells and maintenance of tolerance towards self 
(Sakaguchi, 2004).  
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Hence, tightly controlled balance between effector and regulatory T cell 
populations maintain immune homeostasis. But various ex vivo (alcohol, bacterial 
toxins) and in vivo factors (anti-inflammatory agents) can shift the balance 
between these two T cell populations with opposing effects. For example, alcohol 
and adenosine have long been known to be immunosuppressive (Cook, 1998; 
Hasko et al., 2008; Nelson and Kolls, 2002).  However, the precise molecular 
mechanism through which these molecules alter the immune balance was largely 
unknown. Previous reports have suggested that immune balance is sensitive to 
alterations in TCR signaling pathways (Dragone et al., 2006; Goodnow, 2001).  
Also, differences in the signaling pathways downstream of TCR activation have 
been reported in Treg cells versus effector T cells (Gavin et al., 2002).  In 
particular, our lab had previously reported differential requirement for TCR 
induced phospholipase D (PLD) signaling between effector and regulatory T 
cells. Inhibition of PLD signaling in effector T cells blocked their proliferation and 
survival while it had no significant effect on Treg proliferation (Singh et al., 2006). 
Taken together, these data indicated that PLD signaling in T cells is a critical 
factor controlling the balance between Treg cells and non-Treg cells. 
The goal of my dissertation project was to identify the mechanism of PLD 
regulation in T cells. Based on previous data, we hypothesized that inhibition of 
PLD signal in T cells may promote dominance of Treg cells while activation of 
PLD signaling may promote expansion of effector T cells (Fig 1). We focused on 
the possibility that external factors (alcohol and bacterial toxin) and an 
endogenous factor (adenosine) might mediate immune-suppression by 
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negatively regulating PLD signaling.  Also, the specific role of PLD2 isoform in 
altering the T cell balance was determined using mice with T cell specific deletion 
of PLD2.  Further, we identified the critical region controlling the sub-cellular 
localization of PLD isoforms.   
In the sections to follow, the significance of PLD signaling in T cells and 
rationale and discussion of the experiments performed to address the hypothesis 
is described. 
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                                         Ethanol, Adenosine, 
C.diff toxin
 
 
Fig 1. A schematic presentation of the hypothesis proposed. Active PLD 
signaling following TCR stimulation leads to expansion of effector T cells (white 
circles) accompanied by a modest proliferation of nTreg cells (grey circles). TCR 
signaling in the presence of various exogenous factors (alcohol, bacterial toxins) 
and endogenous factors (adenosine) suppresses PLD signaling thus inhibiting 
the expansion of effector T cells. (Courtesy: Dr.Iwashima) 
 
 
 
 
                                                                                                                                              
 5  
CHAPTER ONE 
LITERATURE REVIEW 
 
THE T LYMPHOCYTE IN IMMUNOLOGY 
 
Introduction 
The immune system can be perceived as an army of organs, tissues, cells 
and molecules that protect the host against a wide variety of invading pathogens 
(Eberl, 2010). The coordinated effort of these various immune components 
provides the host with layered defenses of increasing specificity (Alberts, 2002) . 
At first, the physical barrier like skin prevents bacteria and viruses from entering 
the host. In case of entry into the host, the innate immune response provides an 
immediate but non-specific immune response. If pathogens escape the innate 
immune response, vertebrates are equipped with an adaptive immune system. 
The adaptive immune system makes use of variable receptors to target specific 
pathogen antigens. Also, adaptive immune responses provide faster and 
heightened responses upon re-infection with the pathogen due to maintenance of 
immunological memory. 
Bone marrow derived (B cells) and Thymus derived lymphocytes (T cells) 
are now considered the key mediators of adaptive immune responses. However,
                                                                                                                                                              6
 this was not always the case. Until 1950, the only property known about 
lymphocytes was that they were motile (Miller, 2002). Using tritiated thymidine 
and cannulation of thoracic duct, James Gowans showed that small lymphocytes 
continuously re-circulate from the thoracic duct to blood and secondary lymphoid 
tissue and back to the thoracic duct (Gowans, 1996) (Masopust et al., 2007).  
Miller et al., in 1961 were the first to demonstrate the existence of two major 
interacting subsets of lymphocytes, T and B cells. Further research suggested 
that T cells could be divided into two distinct subsets on the basis of their cell 
surface markers: CD4 and CD8. In terms of their function, CD4 T cells were 
thought to help antibody synthesis (thus, helper T cells) while CD8 T cells 
mediated cytotoxic effect on pathogens. In 1986, Mossman and Coffman showed 
that CD4 T cells were heterogeneous and based on their pattern of cytokine 
production can be further divided into Th1 and Th2 cells.  Recent investigations 
have further expanded the helper T cell subsets into Th17, regulatory T cells and 
follicular helper T cells. Thus, the central role of T cells in orchestrating the 
immune response against a wide variety of pathogens and maintenance of self-
regulatory network has been firmly established.  
Despite the tremendous increase in the knowledge of T cell subsets, their 
specific contribution to disease progression is not well established.  Researchers 
are only now beginning to apply the knowledge gained from scientific 
experiments to therapeutic interventions. 
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Establishing the role and function of Thymus 
Ancient Greeks noted the presence of a large mass of tissue in the chest above 
the heart and they concluded that it had to be the seat of the ‘Soul’ (Miller, 2002). 
The wasting away of the soul after puberty was never addressed (Miller, 2002).  
As early as 1777, William Hewson noted that the thymus was filled with particles 
resembling those in lymph and blood. Also, he believed that the thymus exists 
during the early periods of life only when those particles seem to be most wanted 
(Miller, 2002). Another hematologist, John Beard also echoed the same views as 
Hewson and suggested that thymus must be regarded as the parent source of all 
lymphoid structures of the body and that leukocytes starting from their birth place 
in the thymus penetrate into all parts of the body and perform functions in the 
body (Miller, 2002).  Although, both Hewson and Beard had the right views they 
did not have the right tools and technical skills to demonstrate their idea.  
 In the late 1950s, Gross showed that filtered extracts of leukemic tissues 
from high leukemic strain mice could induce the disease in a low leukemic strain 
of mice if the extracts were injected at birth (Gross, 1951; Miller, 1999, 2002). 
The role of thymus in leukemogenesis was known as it was previously 
demonstrated that adult thymectomy prevented spontaneous mouse leukemia 
developing in high leukemic strains of mice as well as leukemia induced by 
chemical carcinogens. Miller hypothesized that virus given at birth multiplied in 
the developing thymus and thus led to leukemogenic transformation. In order to 
test this hypothesis, he neonatally thymectomized mice. If his hypothesis was 
correct, he expected that neonatal mice lacking a thymus from birth should no 
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longer be susceptible to virus infection and would not develop leukemia when 
grafted with thymic tissue later. However, he found that these neonatally 
thymectomized mice were healthy at first but wasted away after weaning and 
died irrespective of virus inoculation. On the other hand, adult thymectomized 
mice survived and never showed any signs of weight loss or any other pathology. 
This led him to conclude that “ the thymus at birth may be essential to life “(Miller, 
1961).  
Histological examination of the tissues of neonatally thymectomized mice 
displayed a marked deficiency of lymphocytes in the lymphoid tissues and in the 
circulation along with the presence of liver lesions suggesting infection by 
hepatitis virus (Miller, 1999, 2002). Further these mice failed to reject skin grafts 
derived from foreign mouse strains indicating immune deficiency. Conversely, 
inoculation of lymph node/spleen cells or implantation of thymic tissue led to the 
recovery of immunological functions in these mice as efficiently as normal mice 
(Miller, 2002).  In summary, these studies firmly established the crucial role of 
thymus in normal immune system development and function. 
 
Delineation of two major lymphocyte subsets 
Based on the observations of defective cellular immunity and impaired antibody 
producing capacity in neonatally thymectomized mice, it was accepted that 
mammalian thymus produced lymphocytes that participated in both cellular and 
humoral immunity.  In 1962, Burnet and colleagues reported division of labor 
among chicken lymphocytes as they found that early bursectomy was associated 
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with defects in antibody formation and early thymectomy was associated with 
defects in cellular response (failure to reject homografts) (Warner et al., 1962).  
Also, Parrott et al., observed that neonatally thymectomized mice had a 
deficiency of lymphocytes limited to those areas of lymph node and spleen 
associated with histological changes induced by cell mediated immune 
responses but not in those areas where antibody producing cells appeared 
(Parrott et al., 1966). All these emerging data intrigued Dr.Miller and he set out to 
understand the contribution of thymus to the pool of small lymphocytes and to 
antibody forming capacity. Using histocompatibility differences as markers, Miller 
et al., proposed the existence of two major subsets of lymphocytes. They were 
antibody forming cell precursors derived from lymphocytes in bone marrow (B 
cells) and thymus-derived cells (T cells) essential to allow the former to respond 
to antigen by producing antibody and mediating cellular immunity against foreign 
grafts (Miller and Mitchell, 1967) (Mitchell and Miller, 1968). 
Following the reports of two families of lymphocytes, several physical and 
biochemical techniques were developed to distinguish these cell populations on 
the basis of their surface markers, response to a number of mitogens etc (Hirst et 
al., 1975). By 1970, it was widely accepted that T cells reacted with Thy-1 (θ) 
antisera, thus serving as a specific T cell marker (Masopust et al., 2007) (Raff, 
2008).  
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Sub-division of T lymphocytes: CD4 and CD8 
In 1960, Govaerts demonstrated that lymphocytes from immunized 
animals rather than the serum, destroyed allogeneic targets in vitro (Govaerts, 
1960). Interestingly, destruction of T cells with anti-θ antiserum eliminated this 
capability of lymphocytes to destroy allogeneic targets in vitro (Cerottini et al., 
1970).  Several researchers corroborated this finding of cytotoxicity mediated by 
T cells (Golstein et al., 1972). 
T lymphocytes were reported to participate in a variety of cell-mediated 
immune reactions like alloreactivity, cell mediated cytotoxicity and amplification of 
antibody production by B cells (Cantor and Boyse, 1975). However, it was not 
known whether T cells acquire these diverse functions following antigenic 
stimulation or whether functionally distinct T cell subclass were present in non-
immune animals. To address this question, Cantor et al., undertook experiments 
to define cell surface components selectively expressed by T cells mediating 
these distinct functions.  Cantor et al., hypothesized that genes coding for such 
components would be exclusively expressed in T cells. Previous work had 
reported that Ly antigens are expressed exclusively on thymus-derived 
lymphocytes, so Cantor determined if these functionally distinct T cell populations 
could be classified on the basis of expression of different Ly alloantigens. He 
reported that helper T cells exclusively expressed Ly-1 while cytotoxic T cells 
expressed Ly-23.  Also, these subclasses of T cells were found in non-immune 
animals indicating that commitment of T cells to participate in either helper or 
cytotoxic function is a differentiative process independent of antigen exposure.  
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Further, Cantor et al, demonstrated using adoptive transfer of Ly-1 and Ly-23 
expressing T cells into lethally irradiated mice, the absence of inter/ sequential 
conversion of Ly-1 and Ly-23 expressing T cells in the host mice even after 
prolonged periods (Huber et al., 1976). Taken together, these studies 
demonstrated the presence of two functionally different subsets of T-cells, 
representing distinct lineages of thymus-derived lymphocytes. 
Further, researchers extended the surface molecule analysis of T cells to 
humans and found the human analog of Ly-1 as CD4 and Ly-23 as CD8 (Chess, 
2006). Moreover, Rao et al., demonstrated that expression of Ly antigens 
determined major histocompatibility complex (MHC) specificity of T cells in 
addition to their function (Rao et al., 1983).  Thus, CD4+ T cells were found to be 
MHC class II restricted, whereas CD8+ T cells were found to be MHC class I 
restricted (Chess, 2006). Many years of research culminated in the 
understanding of the role of CD4 and CD8 as not just surface markers of T cell 
subsets but rather functionally important molecules involved in the recognition of 
antigen along with the Ag-specific α,β TCR (Chess, 2006).
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HETEROGENEITY OF HELPER T CELLS 
 
 
Introduction 
 
Following the discovery of B and T lymphocytes, Miller performed 
additional experiments using neonatally thymectomized mice and suggested 
possible interactions between B and T cells in antibody responses (Miller, 1999). 
This idea was further strengthened by work of Claman et al., and led to the 
proposal of  the “two cell” theory of antibody production (Claman and Chaperon, 
1969). The discovery of two distinct lymphocyte populations and their synergism 
in antibody production posed many interesting questions to researchers like the 
nature of the contact between these two cells, timing, dosage of antigen, method 
of information transfer etc. The process of answering these questions and much 
technical advancement led to the identification of heterogeneity among helper T 
cells (Fig 2). 
 
Identification of Th1 and Th2 cells 
By 1970, it was generally accepted that a homogeneous population of 
thymus derived T cells participated in both cell mediated immunity (delayed–type 
hypersensitivity reactions) and humoral immunity (helper cells in antibody 
response (Liew and Parish, 1974). In 1971, Parish et al, found an inverse 
relationship between humoral and cell mediated immunity and proposed the 
possibility of different sub-populations of T cells mediating delayed type 
hypersensitivity and helper functions (Liew, 2002; Liew and Parish, 1974). 
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Marrack et al further confirmed the existence of different sub-populations of CD4 
T cells. They demonstrated the presence of antigen specific and non-specific Th 
cells (Marrack and Kappler, 1975). Furthermore, Tada et al., demonstrated the 
presence of two types of helper T cells that act either independently or 
synergistically to help the B-cell response to an antigen (Tada et al., 1978).  He 
further distinguished these subsets of CD4 T cells on the basis of their 
adherence to nylon wool column and the expression of Ia antigen. Accordingly, 
Th1 cells were nylon non-adherent, did not express the Ia antigen and led to 
modest increase in B cell responses, while Th2 cells were nylon adherent, 
expressed the Ia antigen and led to maximal stimulation of B cell responses. 
All of the above-mentioned experiments were conducted by stimulating 
whole T cell fractions isolated from spleen with an antigen, thus depicting 
polyclonal activation of T cells. However, by using the recently established 
method for deriving alloreactive T cell clones (Fathman and Hengartner, 1978), 
Mossman and Coffman established a panel of antigen specific helper T cell 
clones. They categorized these helper T cell clones on the basis of their pattern 
of cytokine production (Liew, 2002). They tested the effect of these cytokines 
(derived by stimulating individual Th cell clones with ConA) on the proliferative 
ability of 3 main cell lines namely HT2, NFS60 and MM3 cell lines (Mosmann et 
al., 1986).  This led to the identification of two distinct types of CD4 T cells. Type 
I cells produced IL-2, IFN-γ, GM-CSF and IL-3 in response to antigenic 
stimulation while type II cells produced IL-3, IL-4 and IL-5 (Liew, 2002).   In line 
with previous observations of Tada et al., type I helper T cell clones enhanced 
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IgG1 production by 10 fold and did not induce Ia expression on B cells while type 
II T cell clones enhanced IgE production by 100 fold and induced Ia expression 
on B cells. Hence, Mossman et al., used the same nomenclature proposed 
earlier and categorized these CD4 T cells as Th1 and Th2 (Liew, 2002). 
Following this discovery using T cell lines, attempts were made to define 
CD4 T cell subsets in mice under physiological conditions. This led to the 
proposal of four different CD4 T cell subsets: cells producing Th1 cytokines, Th2 
cytokines, both Th1 and Th2 cytokines and neither Th1 /Th2 cytokine (Hayakawa 
and Hardy, 1988).  Additional results on the same cell lines led to the proposal of 
a Th0 subset, which produced both Th1 and Th2 cytokines and were thought to 
be uncommitted precursors of Th1 and Th2 subsets of CD4 T cells (Firestein et 
al., 1989). 
 
Development and regulation of Th1 and Th2 cells 
Confirmation of the existence of Th1/Th2 subsets of CD4 T cells led to 
further investigations into their development and mechanisms of regulation. 
Gajewski and Fernandez-Botran et al., reported that the products of Th1 and Th2 
cells could act as autocrine growth factors for further expansion of these cells 
and also reciprocally inhibit the opposite cell type (Liew, 2002).  IFN- γ enhanced 
Th1 cell growth and inhibited the proliferation of Th2 cells while IL-4 promoted 
Th2 cell expansion and limited the proliferation of Th1 cell (Fernandez-Botran et 
al., 1988; Gajewski and Fitch, 1988). 
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 These findings posed many important questions: What initiates the 
development of Th1 versus Th2 cells? Are these cells derived from a common 
precursor that are instructed to differentiate into various lineages or do they arise 
from different precursors that are pre-programmed to develop into different 
lineages? Researchers answered these questions using cells from TCR 
transgenic mice. Hsieh et al, were the first to demonstrate that naïve T cells from 
TCR transgenic DO11.10 mice can develop into both Th1 and Th2 phenotypes 
under appropriate cytokine and stimulation conditions (Hsieh et al., 1992).  
Similar findings by others established that Th1 and Th2 cells have a common 
precursor and that the cytokine microenvironment is the primary determining 
factor of the helper T cell subset fates (Liew, 2002). Over the years, many other 
factors like antigen dose (Hosken et al., 1995), major histocompatibility complex 
haplotypes (Constant et al., 1995) have also been shown to influence the 
differentiation of Th1 and Th2 subsets.  Also, studies were conducted to 
elucidate the mechanism through which cytokines determine the lineage 
decisions of helper T cells. Evidence so far indicates that IL-12 drives Th1 
differentiation through activation of the transcription factor T-bet in T cells through 
STAT4 signaling (Jacobson et al., 1995) (Szabo et al., 2000). Conversely, IL-4 
induces Th2 cell differentiation through activation of another transcription factor, 
GATA3 via STAT6 signaling (Takeda et al., 1996; Zheng and Flavell, 1997). It is 
also proposed that the mutually exclusive expression of T-bet and GATA3 might 
reflect the ability of these factors to antagonize each other (Liew, 2002). 
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Effector functions and disease implications 
 One of the earliest evidence for the role of helper T cell lineages in 
disease pathogenesis was suggested in 1981 based on studies of Leishmania 
major infections. Howard et al reported that BALB/c mice are highly susceptible 
to Leishmania tropica infection compared to C57BL/6 mice (Howard et al., 1980; 
Howard et al., 1981). Further using adoptive cell transfer it was shown that the 
protection of C57BL/6 mice (resistant strain) correlated with an appropriate 
increase in IFN-γ mediated Th1 response and susceptibility of Balb/c mice 
correlated with an inappropriate IL-4 mediated Th2 response (Heinzel et al., 
1989; Scott et al., 1988). Th1 response and IFN-γ were also found to be critical to 
protect hosts from a variety of infections mediated by intracellular pathogens, 
viruses and tumors (Wan and Flavell, 2009). Also, excessive Th1 response has 
been related to incidence of inflammatory diseases like IBD and autoimmune 
diseases like rheumatoid arthritis (Wan and Flavell, 2009). On the other hand, 
Th2 response protects hosts against infections from a variety of extra cellular 
pathogens like helminthes. Th2 responses also participate in mucosal immunity 
and in allergic diseases (Wan and Flavell, 2009). 
 
Th17 cells: new member of effector T cells 
Mossman used the ability of T cell clones to induce footpad swelling as a marker 
for delayed type hypersensitivity reactions (Mosmann et al., 1986). Based on 
these experiments, he proposed that DTH was mediated solely by Th1 cells. The 
lymphocytic infiltrates found in the patients with autoimmune diseases like 
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rheumatoid arthritis (RA) and multiple sclerosis (MS) bear the hallmarks of DTH 
(Steinman, 2007). So based on Mossman’s findings it was hypothesized that 
administration of IFN-γ would worsen EAE (animal model of MS) while blocking 
IFN-γ would ameliorate EAE. Further, one would have also predicted that EAE 
would be attenuated or absent in IFN-γ deficient mice.  
Contrary to these predictions, the results were just the opposite. For 
example, paralysis in the EAE model was worsened in IFN-γ mice. In 2003, 
multiple studies demonstrated that IL-23 knock out mice were resistant to the 
induction of various autoimmune diseases like EAE, IBD and arthritis (Cua et al., 
2003) (Murphy et al., 2003). The cytokine IL-23 is a heterodimeric molecule, 
sharing the p40 subunit with the Th1 cytokine IL-12 but differing from IL-12 
because of its p19 subunit (Steinman, 2007). IL-23 does not promote the 
development of Th1 cells, but instead it is one of the essential factors driving the 
expansion of CD4 T cells producing IL17, IL17F, IL6 and TNF (Langrish et al., 
2005). Using passive transfer studies, authors demonstrated that IL-17 producing 
T cells induced EAE while IFN-γ producing T cells did not (Steinman, 2007).  Cua 
and colleagues showed that EAE, driven by IL-23 and IL-17, was worsened with 
administration of neutralizing antibody to γ-IFN suggesting that Th1 and Th17 
were reciprocal in terms of their function (Cua et al., 2003). 
In an attempt to identify factors that inhibited the TGF-β mediated 
conversion of naïve T cells into Foxp3 expressing T cells, Bettelli et al, 
discovered that TGF-β along with IL-6 led to differentiation of naïve T cells into 
IL-17 producing T cells (Korn et al., 2009).  Not surprisingly, IL-6 knock out mice 
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are resistant to EAE and anti-IL6 improves disease condition in EAE (Steinman, 
2007).  IL-6 or IL-21 in the presence of low amounts of TGF-β result in the 
induction of the steroid nuclear receptor, RORα and RORγt in T cells through 
STAT3 signaling (Korn et al., 2009). However, the mechanism through which 
RORγt regulates Th17 cell differentiation is not yet determined. 
In addition to inducing tissue inflammation in autoimmune diseases like 
EAE and RA, Th17 cells also participate in host defense against variety of 
microbes. Korn et al propose that Th17 cells function in the clearance of specific 
types of pathogens that require massive inflammatory responses, which cannot 
be dealt with by Th1 and Th2 immunity (Korn et al., 2009). Pathogens as diverse 
as Citrobacter rodentium and Candida albicans can trigger Th17 responses 
(Huang et al., 2004; Korn et al., 2009).  Interestingly, Th17 cells are abundant in 
the lamina propria (LP) of the small intestine. Ivanov et al, showed that Th17 
cells are induced in the LP in response to specific components of the commensal 
microbiota, underscoring their importance in maintaining intestinal immunity 
(Ivanov et al., 2008). 
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Figure 2. Heterogeneity of CD4 T cells. Differentiation into different effector 
CD4+ T cell lineages, T helper (Th) 1, Th2, Th17, and T regulatory (Treg) cells is 
initiated following antigenic stimulation of uncommitted (naïve) CD4+ T helper 
cells (Thp). The effector cell types are characterized by their synthesis of specific 
cytokines and their immuno-regulatory functions, as indicated on the right. The 
differentiation along different lineages involves different cytokines and the 
activation of distinct signaling cascades and transcription factors that result in the 
induction of additional cyto/chemokines and cyto/chemokine receptors, which 
may be part of positive and negative feedback loops. Modified from Jetten et al 
((Jetten, 2009) 
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HETEROGENEITY OF REGULATORY T CELLS 
Introduction 
Immunologists have appreciated the concept of self versus non-self 
discrimination by the immune system since the late 19th century. Ray Owen was 
the first to observe the phenomenon of immunological tolerance in vivo when he 
documented the coexistence of two types of erythrocytes in the blood of dizygotic 
cattle twins and the lack of immune reactivity against each other (Owen, 1945; 
Wood et al., 2010). This led Burnet to propose the concept of  “Neonatal 
tolerance” wherein he stated that exposure to an antigen early in life would 
induce specific tolerance to that antigen. Burnet further postulated in his clonal 
selection theory that during ontogeny, antibodies against self-antigens would be 
deleted (Martini and Burgio, 1999; Wood et al., 2010).  
In 1970,Gershon and Kondo reported the finding that T cells not only 
augmented but also dampened immune responses (Gershon and Kondo, 1970; 
Sakaguchi et al., 2007).  This suppressive function was found to be mediated by 
a subset of T cells called suppressor T cells.  It was soon determined that I-J was 
the key suppressor molecule expressed by this subset of T cells. However, no 
such gene could be found within MHC that encoded this molecule (Steinman, 
2007) (Ishii et al., 1982) (Kronenberg et al., 1983). 
 In the 80s, using newly developed tools (monoclonal antibodies and TCR 
transgenic mice) Marrack and von Boehmer’s group reported clonal deletion and 
anergy as key mechanisms of immunological tolerance (Marrack and Kappler, 
1987; Sakaguchi et al., 2007) (Kisielow et al., 1988). Most of these results were 
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inferred from experiments wherein tolerance was induced towards an exogenous 
antigen. 
  The question of tolerance was addressed from a diametrically opposite 
spectrum by investigators like Sakaguchi and Penhale. They studied the effect of 
loss of tolerance towards self-antigens and thus the etiology of autoimmune 
diseases. This led to the identification of a subset of T cell called regulatory T cell 
(Treg cells) that prevented the onset of autoimmunity and is central to the 
maintenance of tolerance to self-antigens. An improved understanding of the 
mechanisms of tolerance has led to new possibilities for the treatment of 
autoimmune diseases (Martini and Burgio, 1999). 
 
Identification of regulatory T cell subset 
Ehlrich postulated “Horror autotoxicus” in 1900 suggesting the 
unwillingness of the organism to endanger itself by the formation of toxic 
autoantibodies (Silverstein, 2001). However, Donath and Landsteiner 
demonstrated that the cause of Paroxysmal cold hemoglobinuria is due to the 
formation of autoantibodies against patient’s own erythrocytes (Silverstein, 
2001). Many other diseases of autoimmune origin were discovered as well but 
these results faded in the wake of biochemical pursuits by scientists to uncover 
antibody–antigen interactions. 
In the late 1960s many studies reported that neonatal thymectomy of 
normal mice/rats (day 3 after birth) led to the development of inflammatory tissue 
damage along with the appearance of tissue-specific autoantibodies in circulation 
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(Penhale et al., 1973; Sakaguchi et al., 2007).   Also, adoptive transfer of CD4 T 
cells from these mice with autoimmune disease was sufficient to induce disease 
in T cell deficient recipients (McKeever et al., 1990).  Interestingly, adoptive 
transfer of CD4 T cells from normal syngeneic animals into thymectomized mice 
inhibited the development of these diseases. Based on these studies, it was 
inferred that there might exist two types of CD4 T cells in the periphery of normal 
untreated mice/rats: one capable of mediating autoimmune disease and the other 
capable of dominantly suppressing them (Sakaguchi et al., 1985). 
Following this, attempts were made to separate these two putative CD4+ 
T cells on the basis of cell surface markers. In 1985, Sakaguchi demonstrated 
that transfer of the CD5low CD4+ T cell subset into nude mice led to the 
development of autoimmunity similar to neonatally thymectomized mice while co-
transfer with normal untreated CD4+ T cells inhibited autoimmunity (Sakaguchi et 
al., 1985). Similar findings by Powrie and Morrissey, demonstrated the role of 
CD45RB  CD4+T cells in mediating autoimmune diseases (Powrie et al., 1993) 
(Morrissey et al., 1993). In 1995, Sakaguchi et al., identified CD25 as a definitive 
marker of CD4 T cells capable of suppressing autoimmune diseases based on 
adoptive transfer studies (Sakaguchi et al., 1995).  As one would expect based 
on previous findings, CD25+ T cells were confined in the CD5 and CD45RB
fraction of CD4 T cells (Sakaguchi et al., 2007). Furthermore, removal of CD25+ 
T cells not only elicited autoimmune disease but also led to enhanced immune 
response against non-self antigens (Sakaguchi et al., 1995). Together, all these 
results collectively led to the identification of thymus derived CD4+ CD25+ T cells 
high
high low 
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that mediates the maintenance of tolerance to self and controls the magnitude of 
immune response to non-self. These CD4+CD25+ T cells were termed as 
naturally occurring regulatory T cells (nTreg cells). 
Around the same time as the discovery of nTreg cells, two other reports of 
CD4 T cells with regulatory properties surfaced. Groux et al., showed that naive 
T cells from OVA TCR-transgenic mice, repeatedly stimulated with OVA and IL-
10, differentiated into T cells with a unique cytokine profile distinct from Th1 or 
Th2 cells (Groux et al., 1997). They produced IL-10, some IL-5, and IFN- , with 
or without TGF- , but showed only marginal or no IL-2 and IL-4 production.  
These cells prevented the development of T cell mediated autoimmune 
responses. Consequently, these cells were designated as type 1 regulatory T 
cells (Tr1) (Jonuleit and Schmitt, 2003) (Beissert et al., 2006) (Fig 3). 
Also, Chen et al., described a subset of T cells in mice that suppressed 
the onset of myelin basic protein (MBP)-specific experimental autoimmune 
encephalitis following induction of oral tolerance to MBP (Jonuleit and Schmitt, 
2003). The suppression of these T cells was primarily mediated through TGF 
(Transforming growth factor)-β and was called T helper type 3 (Th3) cells 
(Beissert et al., 2006)(Fig 3). 
 
Phenotypic and functional characteristics of Treg cells 
+ +Naturally arising Treg cells are mostly CD4 CD25  and constitute 5–10% of 
peripheral T cells in normal mice (Fehervari and Sakaguchi, 2004).  These cells 
suppress cytokine production (e.g. IL-2, IL-4, IFN-γ) and proliferation of antigen-
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receptor stimulated non-regulatory CD4 and CD8 T cells. Although their mode of 
suppression is not clearly understood, emerging studies have put forth many 
interestingly mechanisms that can be broadly classified into three classes: 
contact dependent, soluble factors and killing of target cells. The contribution of 
cell contact dependent mechanisms have been suggested based on the inability 
of Treg cells to suppress effector T cell proliferation when the two populations 
were separated using a semi-permeable membrane (Thornton and Shevach, 
1998). Following cell contact, Treg cells might deliver negative signals to 
responding T cells through increased cAMP levels (Bopp et al., 2007), which is 
inhibitory for T cell proliferation and IL-2 production. Also, production of the 
immunosuppressive nucleoside, adenosine through the action of CD39 and 
CD73 expressed on the surface of Treg cells has been suggested (Deaglio et al., 
2007). Also, Treg cells have been proposed to suppress immune responses 
through cytokine deprivation induced apoptosis of effector T cells (Pandiyan et 
al., 2007). IL-2 is a critical growth/survival factor for Treg cells (Fontenot et al., 
2005).  At the same time, the presence of exogenous IL-2 abrogates the 
suppressive property of Treg cells.  
Although surface phenotype of CD4+CD25+ was originally used to isolate 
these populations, it is not a definitive marker of natural regulatory T cells since 
activated effector T cells also express CD25.  Many other cell surface markers 
expressed by Treg cells are CD38 (Martins and Aguas, 1999; Read et al., 1998), 
CD62L (Ermann et al., 2005; Mudter et al., 2002; You et al., 2004), CD103 (Banz 
et al., 2003), glucocorticoid-induced tumor necrosis factor (TNF) receptor 
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(GITR)(Shimizu et al., 2002), or low levels of cell-surface CD45RB (Powrie et al., 
1996; Powrie et al., 1994; Read et al., 2000; Taams et al., 2001), though none of 
these are exclusive to Treg cells.  Currently, the most reliable marker that 
exclusively distinguishes Treg cells from non-Treg cells is a transcriptional 
repressor Foxp3 (forkhead box P3)(Fontenot et al., 2003; Gambineri et al., 2003; 
Hori et al., 2003; Khattri et al., 2003; Schubert et al., 2001).  Mutations of foxp3 
gene result in severe autoimmune disorders both in human and mouse (Bennett 
et al., 2001; Brunkow et al., 2001; Chatila et al., 2000; Wildin et al., 2001). Foxp3 
gene is required for the production and maintenance of regulatory T cells 
(Fontenot et al., 2003; Kim et al., 2007) and most importantly Foxp3 is not 
induced upon activation of non-suppressive murine CD4+CD25- T cells (Fontenot 
et al., 2003; Hori et al., 2003; Khattri et al., 2003). 
Accumulating evidence suggests that the function of Treg cells is not 
limited to suppression of autoimmunity and they play significant roles impairing 
the immune response to chronic viral infections (Mills, 2004; Mills and McGuirk, 
2004; Rouse and Suvas, 2004; Suvas et al., 2004; Suvas et al., 2003; Toka et 
al., 2004). This was first reported using persistent Friend leukemia virus infection 
of mice (Iwashiro et al., 2001).  Mice infected with this virus have suppressed 
CD8 T cell-mediated immunity against virus-infected cells. When CD4+CD25+ T 
cells are removed from peripheral T cells of infected mice, CD8 T cells markedly 
reduced viral levels during persistence (Dittmer et al., 2004). Increase of Treg 
cells was also reported in cases of infection with HIV (Weiss et al., 2004).   
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Other studies have demonstrated that the frequency of Treg cells 
increases under tumor bearing conditions (Waldmann, 2006), as well as during 
pregnancy (Saito et al., 2005; Zenclussen, 2005). Conversely, decrease of Treg 
cells was reported in cases of autoimmune disease such as multiple sclerosis, 
type I diabetes, and rheumatoid arthritis (Lan et al., 2005).  
 As mentioned previously, regulatory T cells (CD4+Foxp3+) can also be 
induced in the periphery and hence are called “adaptive” or “induced” Treg cells. 
IL-10 producing Tr1 cells proliferate poorly after polyclonal or Ag-specific 
activation in vitro and functional studies revealed that these cells have 
immunosuppressive properties and can prevent the development of T cell-
mediated autoimmune responses (Levings et al., 2002) (Jonuleit and Schmitt, 
2003). Tr1 can control the activation of naive and memory T cells both in vitro and 
in vivo and suppress Th1- and Th2-mediated immune responses to pathogens, 
tumors, and alloantigens (Groux, 2003). Furthermore, supernatants of activated 
Tr1 cells strongly reduce the capacity of dendritic cells (DC) to induce 
alloantigen-specific T cell proliferation (Levings et al., 2002) (Roncarolo et al., 
2001). The suppressive effects of Tr1 cells are reversed by blocking Abs against 
IL-10, showing that the inhibitory capacity of Tr1 cells is mainly mediated through 
production of immunosuppressive IL-10 (Groux et al., 1997; Levings et al., 2002). 
Regulatory Th3 cells are a unique T cell subset induced by orally 
administered Ag in vivo and triggered in an Ag-specific fashion (Jonuleit and 
Schmitt, 2003). They provide help for IgA production and have suppressive 
properties for Th1 and Th2 cells (Jonuleit and Schmitt, 2003; Weiner, 2001a). 
                                                                                                                                                            
 
27
  
However, the suppression of immune responses mediated by Th3 cells are Ag 
nonspecific and can occur as bystander suppression through secretion of TGF-β. 
Because TGF-β is broadly expressed and influences the functional activity of 
multiple cell types, TGF-β secreting Th3 cells probably have a major role in many 
aspects of immune regulation and T cell homeostasis (Weiner, 2001b). 
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Fig 3. Different subsets of regulatory T cells. Naturally occurring regulatory T 
cells mature and migrate from the thymus and constitute 5–10% of peripheral T 
cells in normal mice. The inducible populations of regulatory T cells include 
distinct subtypes of CD4+ T cell: TR1 cells, which secrete high levels of IL-10 and 
TH3 cells, which secrete high levels of TGF-β. TGF-β can also induce Foxp3 
expression CD25- T cells and thus confer regulatory  properties to T cells in the 
periphery. Modified from Milojevic et al (Milojevic et al., 2008). 
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IMMUNE HOMEOSTASIS: POPULATION BALANCE BETWEEN EFFECTOR 
AND REGULATORY T CELL SUBSETS 
The immune system faces the daunting task of protecting the host against 
a wide variety of pathogens at the same time maintaining peace towards self. 
CD4 T cells play key roles in orchestrating both the functions of the immune 
response. As mentioned previously, naïve CD4 T cells specialize to become 
distinct subsets and produce restricted patterns of cytokines that are tailored to 
combat various pathogens. The range of infections afflicting HIV infected 
individuals following decline in their CD4 T cell count underscores the importance 
of CD4 T cells in host defense (O'Shea and Paul, 2010). On the other hand, 
heterogenous populations of CD4+ regulatory T cells suppress the immune 
response to both self and non-self antigens. Adoptive transfer of Treg depleted 
CD4 T cells leads to development of spontaneous autoimmunity, illustrating the 
dominant role of Treg cells in mediating tolerance and autoimmunity. 
Homeostasis of the immune response depends on the balance of 
population dynamics and functionality between these effector and regulatory T 
cell subsets (Mills, 2004). Perturbations in this balance have been reported in 
many diseases. Tang et al, reported that type I diabetes (T1D) progression in the 
NOD mice was associated with a progressive loss of functional Treg cells in the 
inflamed islets (Tang et al., 2008). Conversely, expansion of Treg cells in 
inflammatory mouse models like EAE has been reported to be associated with 
disease resolution (Knoechel et al., 2005) (Korn et al., 2007). 
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Various mechanisms have been proposed to explain the alterations in the 
balance between Treg cells and effector T cells in vivo. The importance of IL-2 
levels in the maintenance of homeostasis is evident from different studies. For 
instance, Tang et al observed that low dose injections of IL-2 supported the 
growth and survival of Treg cells over effector T cells (Teff) whereas a high dose 
of IL-2 led to rapid expansion of effector T cells (Tang et al., 2008). Based on 
these observations they further proposed that Treg cells versus effector T cells 
regulate each other through a feedback loop. IL-2 production by activated Teff 
cells expands and sustains Treg cells, which in turn feeds back to suppress the 
Teff cell response and maintain normal immune homeostasis. Disruption of this 
crosstalk can lead to the dysregulation of the Treg cell: Teff balance thus 
contributing to the development of disease (Tang et al., 2008). 
Recent emerging studies suggest that plasticity and interconvertibility 
among different subset of T cells might also alter the immune balance (Wan and 
Flavell, 2009). Foxp3 expressing T cells from wild type mice lose Foxp3 
expression and exhibit activated-memory phenotype and produce inflammatory 
cytokines (Zhou et al., 2009). Also, fully differentiated Th17 cells were shown to 
convert into Th1 cells in the absence of TGF-β (Lee et al., 2009). However, the 
mechanism and the proportion of T cells undergoing such inter-conversion are 
not known. This newly defined property of CD4 T cells can have far reaching 
consequences in the pathogenesis and treatment of variety of diseases ranging 
from autoimmunity to cancer. 
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Studies of immune evasion by various pathogens also provide clues to the 
mechanisms of alteration of immune balance. One of the common immune 
evasion strategy employed by many pathogens involves increasing the 
production of various immunosuppressive or anti-inflammatory molecules to 
skew the immune response towards regulatory phenotype. Many intracellular 
pathogens and viruses either induce cellular IL-10 or encode their own IL-10 
homolog to delay or suppress the host immune response (Redpath et al., 2001). 
Various environmental toxins have also been shown to tip the immune 
balance between the effector and regulatory T cells. Quintana and Veldhoen et al 
demonstrated that dioxin signaling through aryl hydrocarbon receptor (AHR) 
increased Treg activity and proliferation while activation of AHR by FICZ led to 
increased Th17 activity (Quintana et al., 2008) (Veldhoen et al., 2008). 
Manipulation of the immune balance serves as an attractive target for 
therapy for a range of human diseases. The ideal treatment for autoimmune 
disease would be to decrease the frequency of effector T cells and increase the 
frequency of Treg cells. Several investigators have devised many therapeutic 
strategies to tip the Treg: effector T cell balance. For example, administration of 
monoclonal antibodies to CD3, CD4 or CD40L in the presence of antigen causes 
selective expansion of  Foxp3+ Treg cells, producing the dominancy of Treg cells 
over effector T cells (Wing and Sakaguchi, 2010). Rapamycin, an inhibitor of the 
Akt-mTOR pathway, increases the number of Foxp3+ T cells in part by enhancing 
Foxp3 transcription and by rendering Treg cells resistant to apoptosis (Basu et al., 
2008; Strauss et al., 2007c; Wing and Sakaguchi, 2010). Administration of IL-2–
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anti-IL-2 complexes selectively expands Foxp3+ Treg cell populations (Webster et 
al., 2009; Wing and Sakaguchi, 2010). On the other hand, the ideal treatment in 
the case of tumours would be to increase the frequency of effector T cells and 
reduce the numbers of Treg cells. Administration of anti-CD25 mAb (PC61) has 
been reported to cause reduction in the number of CD4+CD25+ cells thus 
enabling tumour rejection (Onizuka et al., 1999). 
 
Role of TCR mediated signaling pathwyas in altering the immune balance 
The underlying theme in the above mentioned strategies for selective 
expansion/inhibition of Treg cells/Teff is the manipulation of IL-2 and/or IL-2R 
signaling in CD4 T cells. The potential caveat in these strategies is that IL-2 is a 
T cell growth factor for both effector and regulatory T cells and this might lead to 
high variability in the in vivo effect in a heterogeneous patient population.  
An alternative strategy would be to identify specific factors/signaling 
cascades present exclusively in one subset versus the other and to exploit those 
molecules for therapeutic applications. Consistent with this notion several studies 
have reported the role of specific TCR associated signaling molecules  in 
controlling the direction of helper T cell subset differentiation. 
Recognition of MHC–antigen peptide complex by T cell receptor triggers a 
cascade of downstream signaling events. The most proximal biochemical event 
is the tyrosine phosphorylation of the immunoreceptor tyrosine-based activation 
motifs (ITAMs) of the TCR/CD3 complex (Guy and Vignali, 2009; Iwashima, 
2003; Nakayama and Yamashita, 2010). Lck, an Src family tyrosine kinase plays 
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an important role in the tyrosine phosphorylation of ITAMs. Then, the Zap70 Syk 
family kinase is recruited to the phosphorylated ITAMs through the SH2 domains 
of ZAP70. The recruited ZAP70 is then phosphorylated and activated by 
surrounding Lck tyrosine kinase, thus leading to the phosphorylation of LAT 
molecules (Nakayama and Yamashita, 2010). Following these proximal events, 
the activation of various distinct signaling pathways is initiated, including (i) the 
Ras/ERK MAPK cascade, (ii) the Ca/calcineurin/NF-AT pathway, and (iii) the 
PKC/NF-κB pathway (Nakayama and Yamashita, 2010). Interestingly, the 
differential requirement for various signaling molecules involved in both proximal 
and distal events of TCR signaling has been reported in different subsets of CD4 
T cells.  For instance, Lck activity is required for the generation of Th2 cells as 
dominant negative (DN) Lck transgenic mice shows impaired Th2 cell generation 
as against intact Th1 cells (Yamashita et al., 1998). In the same lines, Tan et al., 
showed that PKC is necessary for IL-17 production in the mice (Tan et al., 2006). 
Further, inhibition of ERK/MAPK cascade using pharmacological inhibitor or DN 
Ras results in increased Th1 cell differentiation (Yamashita et al., 1999).  Recent  
studies from our lab group reported the differential requirement for phospholipase 
D (PLD) signaling between regulatory versus non-regulatory T cells. Suppression 
of TCR induced increases in PLD activity led to selective inhibition in the 
proliferation and survival of effector T cells. As a consequence, the frequency of 
Treg cells increased under these conditions. Thus, manipulation of PLD activity 
may serve as a tool to alter the immune balance. Hence, identification of 
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factors/molecules that modulate PLD activity will be of significant therapeutic 
importance. 
 
 
BALANCING ACT OF PHOSPHOLIPASE D (PLD) IN T CELLS 
PLD: structure, function and expression 
PLD belongs to the phosphodiesterase family of proteins, found in 
bacteria, fungi and animals (Melendez and Allen, 2002). Mammalian PLDs 
catalyze the hydrolysis of phosphatidylcholine (PC) to phosphatidic acid (PA) and 
choline (Exton, 2002). Phosphatidic acid is an important lipid second messenger, 
which mediates the downstream effects of PLD signaling. PA is an abundant 
phospholipid that can be also synthesized from pathways other than PLD 
signaling (Athenstaedt and Daum, 1999) . 
  A unique characteristic of PLD is that primary (1–) alcohol serves as a 
more competitive substrate compared to water (> 1000 fold), and the presence of 
1–alcohol effectively blocks PLD signaling (Morris et al., 1997) (Fig 4a).   In the 
presence of 1–alcohol (such as ethanol or 1–butanol), PLD prefers 
transphosphatidylation to hydrolysis and produces phosphatidyl–alcohol, which is 
poorly metabolized.  As a result, the production of PA is significantly reduced.  
Thus, 1-alcohol is a potent suppressive regulator of PLD signaling. 
Two isoforms of PLDs are expressed in mammalian tissues namely PLD1 
and PLD2, which share 55% identity (Frohman et al., 1999). The domain 
structure of PLDs contains phox homology (PX) and pleckstrin homology (PH) 
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domains at the N-terminal followed by four conserved sequences (I-IV) (Sung et 
al., 1999)(Fig 4b). PX and PH domains are implicated in phospholipid and protein 
binding. Results from deletional analysis indicate that PIP2 binds at PH domain 
and at conserved sequences located between catalytic sites II and III (Hodgkin et 
al., 1999) (Sciorra et al., 1999). The catalytic sites II and III contain the 
characteristic ‘HxKxxxxD’ motifs (Frohman et al., 1999). In addition, PLD1 
contains an 116 amino acid ‘loop’ region inserted between the II and III catalytic 
sites. The C-terminal four amino acids of mammalian PLDs are evolutionarily 
conserved and modification of these residues (mutation/deletion) causes loss of 
catalytic activity (Xie et al., 2000) (Liu et al., 2001). PLD1 exists as two splice 
variants, PLD1a and PLD1b that differ in the length of the loop region. This 
region may function as a negative regulator of PLD1 since deletion of the loop 
has been shown to cause modest up regulation of basal catalytic activity of PLD1 
(Frohman et al., 1999). 
Although PLD1 and PLD2 have the same substrate specificity, the 
activities of PLD1 and PLD2 are regulated differently.  PLD1 has low basal 
activity in vitro and it can be stimulated in vitro using agonists as it is coupled to 
receptor signaling via the small GTPases, ARF1/6, Rho, CDC42, and RalA.  PKC 
mediated phosphorylation also up regulates PLD1 activity.  In contrast, PLD2 is 
less responsive to small GTPases and may be constitutively active and regulated 
by inhibition (Colley et al., 1997).   
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A) 
B) 
 
 
 
 
 
 
 
 
 
 
 
Fig 4. Schematic representation of catalytic reaction of PLD and domain 
structure of PLD isoforms found in mice. (A) In aqueous solution, PLD 
catalyzes hydrolysis of phospholipid to yield Phosphatidic acid (PA). But in the 
presence of small amounts of ethanol, PLD yields Phosphatidyl ethanol (PEt). 
R1, R2 and R3 are fatty acid side chains. B) Domain structure of PLD isoforms in 
mice. PX, phox homology; PH, pleckstrin homology domain. Motifs I~IV are 
conserved regions and II and IV contain HKD sequences. Modified from 
(Frohman et al., 1999). 
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PLD1 is mainly found in perinuclear regions, whereas PLD2 localizes 
predominantly in the plasma membrane (Colley et al., 1997; Sung et al., 1997).  
Both PLD1 and PLD2 are palmitoylated in the pleckstrin homology (PH) domain 
and found associated with membrane raft fractions (Sugars et al., 1999; Xie et 
al., 2001). The site of generation of PA and the availability of effector targets 
determines its downstream signaling. Hence, the sub–cellular distribution of both 
the isoforms of PLD is an important factor affecting its function and regulation.  
 
Functions of PA 
PA is now recognized as a vital second messenger for many cell types 
(Andresen et al., 2002; Chen, 2004; Chen and Fang, 2002; Cummings et al., 
2002; English, 1996; Ghosh and Bell, 1997; Houslay and Adams, 2003; Rizzo 
and Romero, 2002). For instance, the direct interaction of PA has been 
demonstrated for several signaling proteins, namely cRaf-1 (Ghosh et al., 1996; 
Rizzo et al., 1999; Rizzo et al., 2000; Wang et al., 2002), mTOR (Chen and 
Fang, 2002; Fang et al., 2003; Fang et al., 2001; Lim et al., 2003), 
phosphodiesterase 4D3 (El Bawab et al., 1997; Grange et al., 1998; Grange et 
al., 2000; Savany et al., 1996), PKC ξ (Bandyopadhyay et al., 2001; Limatola et 
al., 1994),SHP-1(Frank et al., 1999; Tomic et al., 1995) and sphingosine kinase-1 
(Delon et al., 2004).  PA plays a significant role in the regulation of the function of 
these proteins.  The binding of PA to SHP-1, for instance, activates the 
phosphates in vitro (Zhao et al., 1993). PA also functions in protein recruitment.  
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Interactions with PA are essential for the recruitment of cRaf-1 to membranes 
(Rizzo et al., 2000).   
PA is also a precursor for a number of alternative signaling molecules.  
For example, PA can be converted to diacylglycerol (DAG), by phosphatidic acid 
phosphohydrolases (Balboa et al., 1995; Billah et al., 1989; Lassegue et al., 
1993; Mullmann et al., 1990).  DAG is an activator of conventional and novel 
PKC isoforms and other signaling molecules (Cummings et al., 2002; 
Gudermann et al., 2004; Haeffner, 1993; Kikkawa et al., 1989; Yang and 
Kazanietz, 2003).  DAG is also generated by the hydrolysis of 
phosphatidylinositol (4,5)-bisphosphate by phospholipase C (Haeffner, 1993; 
Nishizuka, 1992).  The nature of the DAG species generated by the action of 
phospholipase C differs from that derived from PA through the action of 
phospholipid phosphohydrolases (Liu et al., 1999; Plo et al., 2000). The 
consequences of this difference are currently unknown. 
Hence, PA mediates a variety of cell functions including cell survival, 
proliferation, cytoskeletal rearrangement and vesicular trafficking (Fang et al., 
2001; Ghosh et al., 1996; Lim et al., 2003; Rizzo et al., 1999). However, the 
precise role of PA in modulating T cell function and survival is not clear. 
 
Regulation of catalytic activity of PLD  
Various in vitro studies have elucidated the role of certain co-factors in the 
catalytic activation/inactivation of PLD. They can be classified into 3 classes. 
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i. Phospholipids 
PIP2 was determined to be essential for catalytic activity of PLDs (Brown et al., 
1993). PIP3 is also effective in up regulation of PLD activity. A PIP2 binding site 
is located between conserved regions II and III of the catalytic domain and 
mutation in this region abrogates PLD activity without altering their sub cellular 
localization (Frohman et al., 1999). Another PIP2 binding site has been reported 
to be present within the PH domain. This binding site affects PLD activity by 
altering their sub cellular localization (Oude Weernink et al., 2007). 
ii. Small GTPase 
Several small GTPase’s can activate PLD. Activation of PLD1 by ARF is GTP 
dependent and requires the N-terminal region of PLD. However, the detailed 
mechanism of PLD activation by ARF is not known (Frohman et al., 1999). 
Several Rho family proteins, namely RhoA, Rac and CDC42 are also involved in 
PLD activation. Invitro, GTPγs activated forms of these proteins have been 
shown to activate PLD (Hammond et al., 1997). Botulinum C3 toxin has been 
reported to block PLD activation by inactivating Rho (Malcolm et al., 1996; 
Schmidt et al., 1996). C-terminus of PLD1 is reported to be the interaction site for 
Rho (Du et al., 2000). 
Iii     PKC 
Treatment of cells with phorbol esters effectively activated PLD, suggesting that 
Protein Kinase C (PKC) is upstream of PLD activation (Exton, 2002). Several 
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phosphorylation dependent and independent modes phosphorylation by PKC has 
been reported (Hammond et al., 1997). 
 
TCR signaling and PLD  
Attachment of the T cell receptor complex by its cognate antigen triggers a 
cascade of downstream signaling events including phosphorylation of ITAM 
motifs, phosphoinositide hydrolysis and calcium flux. Emerging results indicate 
that antigen receptors that transduce signals via immuno–receptor tyrosine 
based activation motifs (ITAMs) are coupled to PLD activation (Melendez and 
Allen, 2002). Fcγ and ε receptors activate PLD by the antigen-antibody complex 
(Cockcroft et al., 2002; Gewirtz and Simons, 1997; Gruchalla et al., 1990; Jose 
Lopez-Andreo et al., 2003; Kusner et al., 1999; Loegering and Lennartz, 2004).  
TCR stimulation was also shown to upregulate PLD activity by 2~300% (Reid et 
al., 1997).  Inhibition of PLD activity in T cell line caused loss of AP-1 activation, 
cytokine production and proliferation (Mollinedo et al., 1994).  BCR was also 
shown to activate PLD (Forssell et al., 2000; Hitomi et al., 1999).   
Previously our lab group had demonstrated that PLD1 and PLD2 signaling 
are involved in different stages of TCR signaling (Singh et al., 2006). Over 
expression of both PLD1 and PLD2 potentiated NF-AT activation by TCR in 
Jurkat cells. CD2/ZAP-70, a fusion protein between the extracellular and 
transmembrane domains of CD2 with Zap-70 activates NFAT when expressed in 
Jurkat cells. When co-expressed with CD2/Zap-70, PLD1 induced marked 
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upregulation of NFAT activity whereas PLD2 induced only a slight upregulation. 
Conversely, lipase inactive PLD2 but not PLD1, blocked anti-TCR antibody 
induced tyrosine phosphorylation of TCR ζ. Together, the data indicated that 
PLD2 is required for TCR signaling events proximal to the recruitment of Zap-70 
to ITAM while PLD1 is involved in events distal to tyrosine phosphorylation of ζ. 
 It is not yet clear how PLDs are coupled to TCR. Several groups have 
reported the presence of PLD enzymes in caveolae, which are specialized 
domains of the plasma membrane, related to sphingolipid and cholesterol-rich 
micro domains or rafts (Gidwani et al., 2003; Hekman et al., 2002; Zheng et al., 
2003).  In view of the fact that molecules with a key role in T cell signaling like 
Lck also localize to these domains, it is tempting to suggest that lipid rafts might 
provide the perfect platform for PLD and TCR coupling. 
 In our recent study, we also demonstrated that the increase in PLD activity 
after TCR stimulation was two fold in CD4+CD25- cells and rather unchanged in 
CD4+CD25+ T cells. Moreover, PLD1 expression was substantially lower in 
CD4+CD25+ cells than in CD4+CD25- cells indicating differences in the 
requirement for PLD signaling between regulatory and non-regulatory T cells. 
Inhibition of the TCR induced increase in PLD activity in CD4+CD25- T cells 
substantially affected their activation; proliferation and cytokine secretion while it 
had no effect on CD4+CD25+ T cells. Consequently, culture of heterogeneous 
population of naïve CD4 T cells in the presence of TCR stimulation and 
exogenous IL-2 led to preferential expansion of Foxp3+CD4+ T cells. Moreover, 
these expanded Treg cells exhibited potent immune suppression in a mouse 
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model of inflammatory bowel disease (IBD) indicative of their functional 
capabilities. These data also illustrated the biological significance of PLD 
signaling in T cells. Investigations to elucidate the anti-proliferative effect of 
inhibition of PLD signaling on CD4+CD25- T cells suggested that blockade of 
high affinity IL-2 receptor (CD25) expression may be a factor. However, the 
precise molecular mechanism of regulation of CD25 expression by PLD is still 
unknown. Also, the specific function of the PLD isoforms in mediating this 
differential effect on CD4 T cells is unknown. 
 
Modulation of PLD activity by extracellular stimuli 
The above mentioned data suggested to us that PLD signal regulation 
could play a pivotal role in controlling the balance between regulatory and non-
regulatory T cells. In vivo suppression of PLD signaling may promote dominance 
of naturally arising Treg cells under physiological conditions. Conversely, 
augmenting PLD signaling may promote growth of effector T cells and break the 
immune suppression by Treg cells. This led us to ask: Is it possible for 
pathogens/tumours to inhibit PLD activity (directly / indirectly through secretion of 
factors) to subvert the protective immune responses of the host? Alternatively, 
does elevated PLD activity contribute to autoimmune responses? 
There have been a number of studies that indicate the modulation of PLD 
activity by various extracellular stimuli. These stimuli in turn mediate their effect 
on PLD through the help of above-mentioned cofactors of PLD signaling.  Alcohol 
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is an exogenous factor that alters the immune phenotype of the host (Nelson and 
Kolls, 2002).  T cells from individuals who were exposed to alcohol both 
chronically and acutely showed a higher frequency of T cells expressing CD25 
(Cao et al., 1998; Laso et al., 1996a; Laso et al., 1996b; Sacanella et al., 1998; 
Santos-Perez et al., 1996).  One study showed that these T cells were 
exclusively CD4+ (Laso et al., 1996b).  Moreover, the frequency of CD25+ T cell 
remained high even 9 months after alcohol withdrawal.  In another study, clear 
positive correlation was observed between total estimated life time dose of 
ethanol consumed and the percentage of PBLs expressing CD25 (Sacanella et 
al., 1998).  Our studies suggested that these effects might be channeled through 
suppression of PLD signaling and increased frequency of Treg cells. 
Pathogens like Clostridium difficile might also alter the host immune 
response through PLD signaling. The major virulence factors produced by 
C.difficile are Toxin A (TcdA) and Toxin B (TcdB) (Genth et al., 2008). Inside the 
host cell, these toxins mono-glucosylate and thereby inactivate small G proteins 
of the Rho sub-family (Genth et al., 2008). Since PLD is one of the downstream 
effector molecules of Rho, these toxins indirectly inhibit PLD activity (Schmidt et 
al., 1996). We propose that the functional consequence of inhibiting PLD 
signaling is enrichment of Treg cells. This in turn might facilitate the evasion of 
host immune response by C.diff through elimination of the effector response by 
non-Treg cells. 
 The receptor system that has been linked to PLD regulation includes G-
protein coupled receptors and tyrosine kinase coupled receptors (Frohman et al., 
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1999). G-protein coupled receptors include chemokine receptors (RANTES, IL8) 
(Bacon et al., 1995; Bacon et al., 1998), adenosine receptors (Selvatici et al., 
2006; Thibault et al., 2002), N-formyl peptide receptor (FPR) (Selvatici et al., 
2006), P2Z/P2X7 nucleotide receptor (Coutinho-Silva et al., 2003) and 
prostaglandin (PGE2) receptors (Burelout et al., 2004). Tyrosine kinase coupled 
receptors include TCR, BCR, FcReRI, and FcRI (Melendez and Allen, 2002)  and 
Insulin receptors (Farese, 1988).  
These extracellular stimuli alter PLD activity in both a positive and 
negative manner. Antigen and chemokine receptors elevate the activity of PLD 
(Bacon et al., 1995; Bacon et al., 1998).  FPR, which recognizes bacterial 
peptides, also elevates PLD activity (Selvatici et al., 2006).  On the other hand, 
inflammation related receptors, including adenosine receptors (Selvatici et al., 
2006; Thibault et al., 2002), lipoxin A (4) receptor (Levy et al., 1999) and PGE2 
receptors (Burelout et al., 2004) suppress PLD activation.  Interestingly, a recent 
report indicated that PGE2 induces enrichment of regulatory T cells (Baratelli et 
al., 2005). 
Most of the studies indicate that PLD1 is associated with receptor induced 
PLD activity and this involves the role of small GTPases or PKCs whereas PLD2 
may be constitutively active and is a target of negative regulation. In contrast to 
the activation process of PLD, the process that inactivates PLD is not well 
characterized. Adenosine (A2a) receptor signaling in neutrophils (Thibault et al., 
2002) and A3 receptor signaling in ischemic heart  (Mozzicato et al., 2004) has 
been shown to modulate PLD activity. PGE2 receptor has also been shown to 
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inhibit PLD activity. Both A2a and PGE2 stimulate adenylate cyclase and thereby 
increase the intracellular cAMP levels. These data indicate that downstream 
targets of cAMP, such as PKA may mediate suppression of PLD activity. 
However, no clear connection between PKA and PLD has been made at this 
point. Interestingly, a recent report showed that βγ subunits of G protein could 
inhibit PLD1 activity by direct interactions (Preininger et al., 2006). Other 
negative regulatory factors of PLD include ceramide (Nakamura et al., 1996), 
presqualene diphosphate (PSDP) (Levy et al., 1999) and munc-18-1 (Lee et al., 
2004). 
 
Adenosine and PLD signaling 
Adenosine (Ado) is a purine nucleoside formed from its precursor ATP by 
the action of CD39 [nucleoside triphosphate dephosphorylase (NTPD)] and 
CD73 (5-ectonucleotidase)(Hasko et al., 2008). Adenosine is constitutively 
present at low concentrations in extracellular space however metabolically 
stressful conditions (hypoxia, cell death) increase its levels in extracellular space 
drastically (Fredholm et al., 2001; Linden, 2001).  Numerous studies suggest the 
role of Ado as an immune modulator.  First, high concentrations of Ado represent 
a pre-eminent alarm signal indicating tissue injury to the surrounding cells.  
Secondly, Ado occupies its cognate receptor present on a variety of immune 
cells including dendritic cells (Panther et al., 2003; Schnurr et al., 2004), 
neutrophils (Cronstein et al., 1983) and lymphocytes and mediates immune 
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suppression (Borsellino et al., 2007; Hasko et al., 2008; Kobie et al., 2006; Zarek 
et al., 2008).  A physiological response of Ado is elicited by engaging one or 
more of the four G-protein coupled receptors (A1, A2a, A2b and A3) (Jacobson 
and Gao, 2006).  
Recent studies have elucidated an important role for adenosine in 
mediating the immunosuppressive properties of Treg cells.  It was demonstrated 
that Treg cells express CD39/CD73 and thus hydrolyze extra cellular ADP and 
ATP to adenosine (Deaglio et al., 2007; Kobie et al., 2006).  Also, Treg cells 
isolated from CD39 knockout mice do not suppress the proliferation of 
CD4+CD25- cells, indicating the role of CD39 in modulating Treg function 
(Deaglio et al., 2007).  Similarly, Treg cells isolated from wild type mice failed to 
suppress CD4+CD25- cells from A2a receptor knockout mice (Naganuma et al., 
2006; Zarek et al., 2008). Numerous studies have established the 
immunosuppressive function of A2a receptor signaling. Indeed activation of A2a 
receptor on Treg cells causes upregulation of Foxp3 expression (Zarek et al., 
2008). Interestingly, A2a receptor occupancy on neutrophils reduces PLD activity 
by limiting the recruitment of Arf, RhoA, and PKC  to membranes (Thibault et al., 
2000). 
The combined effects of activated adenosine A2 and A3 receptors (A2AR, 
A3AR) on mononuclear cells of the immune system are considered anti-
inflammatory (Hasko et al., 2008; Jacobson and Gao, 2006). Activation of A3 
receptors on macrophages inhibits the release of tumor necrosis factor alpha 
(TNF-α) and thus exerts beneficial effect in treating inflammatory disorders like 
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arthritis (Baharav et al., 2005). Conversely, A3 receptor activation on mast cells 
triggers histamine release (Salvatore et al., 2000) and thus is an important player 
in mediating asthma (Hasko et al., 2008). In addition, A3 receptors have been 
demonstrated to utilize PLD and RhoA in dictating cell functions. However, the 
precise function of A3 receptor in T cells has not been established.  
Based on these studies, we set out to determine the effect of adenosine in 
modulating PLD signaling in T cells. We also tested if PLD signaling plays any 
role in mediating the immune suppression of adenosine. 
 
CONCLUSION 
The heterogeneity of T cell subsets has led us to appreciate the functional 
importance of CD4 T cells in fighting pathogens, inducing autoimmunity as well 
as maintaining tolerance to self. It is widely accepted that the population balance 
between the various subsets of CD4 T cells is central to maintaining immune 
homeostasis. Hence, identification of factors controlling this population balance 
like PLD signaling will provide novel therapeutic strategies for controlling variety 
of diseases ranging from autoimmunity to tumors. 
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CHAPTER TWO 
 
MATERIAL AND EXPERIMENTAL METHODS 
 
Mice 
All mouse work was done in accordance with the Animal Care and Use 
Committee guidelines of Medical College of Georgia and Loyola University. 
Animals were housed in pathogen-free conditions prior to manipulations. 
C57BL/6 mice and RAG-1 knock out mice were obtained from Jackson 
laboratory. CD4 CRE mice were obtained from Taconic. P25 TCR transgenic 
mice was generously gifted by Dr. T. Saito (Japan) (Tamura et al., 2004). 
D011.10 TCR transgenic mice were housed in pathogen free facility in Medical 
College of Georgia (Augusta, Georgia, USA).  
       Generation of PLD2 -/- mice 
PLD2fl/fl mice were generated by selecting the PLDneo ES cell clone 
(Mayuko Takezaki). The floxed mouse PLD2 (PLD2fl/fl) mice line was bred with 
FLP transgenic mice to delete the neo transgene. Then PLD2fl/fl (minus neo) 
mice were bred with mice carrying CD4 cre transgene. Mice were routinely 
screened by genotyping of the tail DNA using PCR. Primers used for genotyping
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are listed in Table I.  Genomic DNA was isolated from CD4 T cells and analyzed 
by southern genomic blot for targeted recombination. 
 
Southern Blot 
Genomic DNA was isolated from CD4 T cells using standard procedures 
(Blin and Stafford, 1976). Ten micrograms of genomic DNA was digested with 
the restriction enzyme Bgl II, electrophoresed on a 0.7% agarose gel, transferred 
to Hybond-N and UV cross-linked according to the manufacturer’s suggestion 
(Amersham Pharmacia Biotech). Filters containing the immobilized DNA were 
incubated with 1-5*106 cpm/ml of radio labeled probe. 25ng cDNA-probe was 
labeled with 32P using the Prime It® II Random Primer Labeling Kit (Stratagene 
#300385). The PLD2 targeting probe corresponds to a 340bp XhoI-EcoRI 
fragment located immediately upstream of the short arm of the targeting 
construct. Filters were washed at 65 °C in a solution containing 0.1X SSC and 
0.1% SDS and analyzed by autoradiography. 
 
Adoptive transfer 
CFSE labeled (0.5uM) (donor) p25 CD4 T cells (2.5-5×106 ) were injected 
intravenously into Ly5.1 (recipient) mice on day 0. Recipient mice were injected 
with 2.5ug of p25 peptide intravenously on day 1. Recipient mice were given 
intraperitoneal injections of vehicle (DMSO in PBS), AB-MECA (200ug /kg), 
Ethanol (2.9g/kg body weight in 20% vol/vol) in 200 ul from day 0-6. Mice were 
sacrificed on day 8 and spleen, mesenteric lymph nodes and all peripheral lymph 
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nodes (axillary, brachial, cervical, inguinal and popliteal) were harvested and  
intracellular staining for Foxp3 expression was performed. Proliferation function 
in flowjo software was used to determine number of cells in each cell division. 
RAG1 -/- mice 
CFSE (0.5uM) labeled CD4 T cells (1- 5x106) from wild type B6 mice were 
intravenously transferred into recipient RAG1-/- mice. Mice were injected with 
ethanol or PBS intraperitoneally as described previously for 5 days. Mice were 
sacrificed on day 6 and splenocytes were analyzed for Foxp3 expression by flow 
cytometry. 
 
Cell isolation and culture  
Splenic CD4 T cells were isolated using either positive or negative 
selection kit from BD Biosciences or MACS Miltenyi Biotec as per manufacturers 
protocol. Cell purity was confirmed to be 95% by BDFACS Canto. Cells were 
cultured in vitro in RPMI 1640 medium supplemented with 10% v/v heat-
inactivated FBS, 2mM glutamine, 5×10-5 M 2-ME, and 100 U/mL penicillin and 
100 µg/mL streptomycin (all were obtained from Thermo Scientific Hyclone).  
Treg enrichment  
61×10  CD4 T cells were pre-incubated with DMSO, AB-MECA (A3R agonist, 
SIGMA), 0.5 % ethanol (SIGMA, 200 proof) and 2 % ethanol (2ml in 24 well 
plate). After 16 hrs, we replaced 1.5 ml of culture supernatant with fresh medium 
containing 0.2ug/ml of anti-CD3 (e-bioscience), γ-irradiated splenocytes (2500 
rad) (2-5×106 cells/well) and different treatment constituents like DMSO. We 
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replaced 1 ml of medium for the next 72 hrs with medium containing anti-CD3, 
2ng/ml of mouse recombinant IL-2 and respective treatment constituents. We 
washed the cells on day 4 and cultured them with IL-2 (2ng/ml) for next 3 days. 
On day 7, cells were harvested, washed and counted. Cells were then stained 
with different fluorescent antibodies and analyzed by flow cytometry. 
Activation markers 
1×106 CD4 T cells were activated with anti-CD3 (0.2ug/ml) and APCs (T 
cell depleted γ-irradiated splenocytes (2500 rad), (2-5×106 cells/well) in the 
presence of DMSO, AB-MECA, varying concentrations of ethanol and C.difficile 
culture supernatants. 24 hrs later cells were harvested and analyzed by flow 
cytometry. In some experiments, CD4 T cells were further sorted into CD4+ 
CD25+ and CD4+ CD25- T cells using BDFACSAria. 
CFSE labeling 
Purified CD4 T cells were labeled with 2.5μM CFSE (Invitrogen) for 10 min 
at 37°C in PBS. The reaction was quenched by the addition of medium 
containing 10% FCS and then washed twice in PBS. CFSE labeled cells were 
cultured for 7 days as mentioned above. In some experiments, cells were labeled 
with 2.5uM PKH-26 (a red fluorescent cell labeling dye, SIGMA). Cells were 
harvested on Day 5 after stimulation. 
            Cytokine assay 
To analyze cytokine production by ELISA, CD4 T cells were stimulated 
with plate bound anti-CD3 (2 ug/ml) and soluble CD28 (1 ug/ml) in the presence 
                                                                                                                                                            
        
52
                                                                
 
 
of DMSO or AB-MECA. Supernatants were collected at 24, 48 and 72 hrs and 
enzyme linked immunoassays were performed as described previously. 
To detect cytokine production by intracellular staining, CD4 T cells were 
stimulated with plate bound anti-CD3 (2ug/ml) and soluble CD28 (1ug/ml) for 48-
72 hrs. Cells were then rested for 48 hrs in the presence of IL-2. On day 5, cells 
were washed and 1×106 were restimulated with PMA (50ng/ml) and Ionomycin 
(1ug/ml) for 6 hrs in the presence of Golgistop (Monesin, 2uM). Cells were then 
harvested and stained with fluorescent antibodies and analyzed by flow 
cytometry. 
Th1, Th2 and Th17 skewing conditions 
For Th1 skewing conditions, CD4 T cells were stimulated as before and 
cultured in media supplemented with mIL-12 (10ng/ml) and anti-IL-4 (10ug/ml). 
After 48 hrs, medium was supplemented with additional IL-2. 
For Th2 skewing conditions, CD4 T cells were stimulated as before and 
cultured in media supplemented with mIL-4 (10ng/ml), anti-IL-12 (10ug/ml) and 
anti-IFNγ(10ug/ml). After 48 hrs, medium was supplemented with additional IL-4.     
Cells skewed to Th17 were supplemented with TGF-β (2ng/ml), mIL-6 
(10ng/ml), anti-IL-4 (2ug/ml) and anti-IFNγ (2ug/ml). Th17 skewed cells were 
harvested on day3 or 4 washed and stimulated with PMA and Ionomycin and 
analyzed by flow cytometry. Th1 and Th2 skewed cells were harvested on day5 
after stimulation and restimulated with PMA and ionomycin. 
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Induction of Treg cells 
To test for induction of Treg cells, CD4+CD25- T cells were stimulated 
with APCs (whole splenocytes) and anti-CD3 (0.2-0.4ug/ml). Medium was 
supplemented with AB-MECA or DMSO. TGF-β (5ng/ml) was added to positive 
control wells. IL-2 (2ng/ml) was added to all wells on day 1 and day 2. Cells were 
harvested on Day 5 or 6 and analyzed for Foxp3 expression by flow cytometry. 
 
Flow cytometry 
Cell surface staining 
  Cells in culture were harvested and washed once with FACS buffer (5% 
FCS and 0.1% azide in 1X PBS). 1x10
6 
cells were stained with various antibodies 
for 1hr at 4 degree and cells were washed three times with FACS buffer. Before 
staining with antibodies, cells were incubated for 5-10 mins with 2.4G2(FcR 
block). Purified, fluorochrome and biotin-coupled monoclonal antibodies specific 
for CD4 (RMA 4–4, GK1.5), CD8 (53–6.7), CD25 (PC61, 7D4), CD3 (145-2C11) 
and FoxP3 (FJK-16s) were purchased from eBiosciences (San Diego, CA). Thy 
1.2, Ly 5.2 and Vβ11were purchased from Biolegend (San Diego, CA). 
Fluorescent antibodies against IL-2, IL-4, IFN-γ was purchased from e-bioscience 
and IL-17 was purchased from Biolegend. 
 Intracellular cytokine staining 
0.5-1x10
6 
cells were surface stained and then fixed for 15 mins with 4% 
Paraformaldehyde (Sigma) at room temperature. Cells were diluted with FACS 
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buffer and kept at 4 degrees overnight. The following day, cells were washed and 
incubated with permeabilization buffer (50mM Nacl, 5mM EDTA, 0.02% Azide, 
0.5 % Triton-X pH7.5) for 15 mins followed by blocking (3% BSA in PBS). Cells 
were then incubated with fluorescent antibodies for 45 mins on ice. Finally, cells 
were washed three times in FACS buffer and analyzed by flow cytometry. 
Intracellular Foxp3 staining 
1x10
6 
cells were surface stained with anti-CD4 and anti-CD25, fixed 
overnight with Fix/Perm buffer (eBioscience). After 12-16 hrs, cells were then 
washed twice with IX permeabilization buffer (eBioscience) and stained with anti- 
Foxp3 antibody in IX FACS buffer at 4°C for 1hr. Cells were washed thrice with 
IX FACS buffer and analyzed by flow cytometry. 
All the data was acquired using FACSCanto or FACSCanto II (Becton 
Dickinson) at the LUMC FACS Core Facility, and data was analyzed using 
FlowJo analysis software (©Tree Star, Inc).  
 
T cell proliferation assay 
CD4 T cells (2x104 – 3x104) were stimulated with anti-CD3 (0.2ug/ml) and 
(T cell depleted splenocytes, γ-irradiated, 2500 rads) APCs in 96 well plates 
(200ul). Depending on the experiment, medium was supplemented with DMSO, 
AB-MECA, and 0.5%-2% ethanol and toxin or no-toxin supernatants from 
C.difficile culture. 72 hrs after stimulation cells were assayed for proliferation 
using CellTiter-Glo Luminescent cell viability assay (Promega). The kit uses 
luciferase as the detection enzyme. Luciferase enzyme requires ATP to generate 
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light. Since metabolically active cells produce more ATP, the light signal detected 
is proportional to the amount of ATP present that in turn correlates with the 
number of viable cells. Luminescence is measured using plate reader (Turner 
Biosystems) and analyzed using VERITAS software. 
 
ELISA 
96 well plates were coated with purified mIL-2, mIL-4 or mIFN-γ (capture 
antibody, 1:500-1:1000) in 0.1M NaHCO3 buffer overnight at 4 deg. Next day, 
wells were washed twice in ELISA wash buffer (0.05% Tween in 1xPBS) and 
blocked with blocking buffer (3% BSA in PBS) at room temperature for 1 hr. Then 
the wells were washed again and incubated with sample supernatants (serially 
diluted in 1:3) overnight at 4 deg. The following day wells were washed and 
incubated with biotin-conjugated antibodies (mIL-2, mIL-4 or mIFN-γ) for 1-2hrs. 
Further, streptavidin-HRP (1:1000) was added and incubated for 30 mins at room 
temperature. 100ul of 3,3', 5,5’-Tetramethylbenzidine (TMB) liquid substrate 
(Sigma, St. Louis, MO) was added to each well after washing the plates five 
times with wash buffer. Upon color development, the reaction was stopped by 
adding 50ul of stop buffer (4 water: 1 HCl: 1 H2SO4) to the wells. The plates were 
then read at 450 nm using plate reader (Biotek, El x 800) and the data was 
analyzed using KC junior software. 
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Phospholipase D Assay 
Lymphocytes were harvested from P25 TCR transgenic mice and 
incubated overnight with (1-10ug/ml) P25 peptide. The following day cells were 
harvested, washed with RPMI three times to remove any residual antigen 
peptide. CD4 T cells were sorted and kept at room temperature until use. Cells 
were then suspended in 10% RPMI containing 10mM HEPES (1-5x106/500ul) 
and pretreated with DMSO or AB-MECA (50uM) for 30 mins in 37 deg water 
bath. Following pretreatment, CD4 T cells were stimulated with soluble biotin 
conjugated anti-CD3 and avidin for different time points (15-30 mins). Cells were 
centrifuged and resuspended in RIPA lysis buffer (10mM phosphate buffer pH 
7.2,150mM NaCl, 1% Triton-X, 0.5% sodium deoxycholate, 0.1% SDS) 
containing Dnase. Cell lysates were assayed using the commercially available 
Amplex Red PLD assay kit (Invitrogen (Molecular Probes)). In this assay, PLD 
activity is monitored indirectly by using 10-acetyl-3, 7-dihydrophenoxasine, called 
the Amplex Red reagent. PLD cleaves the L-α-phosphatidylcholine (PC) substrate 
to yield choline and phosphatidic acid. Choline is oxidized by choline oxidase 
(provided in the kit) (choline oxidase from an Alcaligenes sp.) to betaine and 
H2O2. Finally, H2O2 in the presence of horseradish peroxidase reacts with the 
Amplex Red reagent to generate the highly fluorescent product resorufin 
(excitation and emission maxima, ~563 and 587 nm, respectively), an H2O2 
fluorogenic sonde. As per manufacturers manual, this kit is specific for 
membrane PLD enzymes, with optimal activity at nearly neutral pH (pH 8). 
Purified PLD from Streptomyces chromofuscus and 10 μM H2O2 served as 
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positive controls. The PLD assay kit can detect PLD levels as low as 10 mU/ml. 
One unit of PLD is defined as the amount of enzyme that liberates 1.0 μmol of 
choline from PC per minute at pH 8.0 at 30°C. Cell lysates were incubated with 
the reagents provided in the kit for 1hr at 37 deg and the fluorescence intensity 
was read using fluorometer (BMG Labtech). 
 
cAMP Assay 
CD4 T cells from P25 transgenic mice were sorted and stimulated as previously 
described in PLD assay. In the case of cAMP assay, CD4 T cells were stimulated 
for 5 mins. Further, to assess cytosolic cAMP concentrations, T cells were 
washed three times in ice-cold PBS, lysed in 0.1 N HCl (107/ml) for 30 mins. 
Supernatants were assayed using the acetylated version of cAMP-specific ELISA 
kit (Correlate EIA Direct Cyclic AMP Enzyme Immunoassay kit; Assay Design). 
 
Western Blots 
In general, cell pellets were suspended in 1xSDS sample buffer (0.5-1x106 
cells in 25 ul) and boiled for 5-7 mins with intermediate vortexing. The proteins 
were then separated on 8% polyacrylamide gels. Proteins were then transferred 
to nitrocellulose membrane (Millipore) overnight in transfer buffer. The following 
day membrane was blocked with 5% milk in TBST for 1 hr. Blots were then 
washed three times in 1X TBST and incubated with the primary antibody 
overnight at 4 deg. Next day, blots were washed and incubated with secondary 
antibody for 1 hr at room temperature. ECL substrate (GE healthcare) was 
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added to the blot for 1 min before developing.  
To determine adenosine A3 receptor expression, CD4+CD25+ and 
CD4+CD25- T cells were sorted using MACS column. Cells were stimulated with 
plate bound anti-CD3 (2ug/ml) and anti-CD28 (2ug/ml) for 72 hrs. Both 
unstimulated and stimulated cells were harvested, washed in 1xPBS and 
pelleted. Cells pellets were processed as described above. Adenosine A3 
receptor antibody (Santa Cruz Biotechnology, 1:500) was diluted in antibody 
dilution buffer (0.2% BSA, 0.1% azide in 1X TBST). Anti-rabbit HRP (Cell 
Signaling, 1:5000) was used as secondary antibody. The membrane was 
stripped with buffer containing 2-ME and probed with β-actin (Sigma) antibody. 
For phospho PKA analysis, splenocytes from P25 TCR transgenic mice 
were stimulated as described in PLD assay. Sorted CD4 T cells were incubated 
with AB-MECA or DMSO for 30 mins before stimulation. T cells were stimulated 
with biotin anti-CD3 (2C11, 10ug/ml) for 1 min followed by addition of 2.5ug/ml of 
avidin for 5 mins at 37 deg. Cells were then pelleted and processed as described 
above. Phospho-PKA substrate antibody (Cell Signaling, 1:1000) was diluted in 
antibody dilution buffer. Anti-rabbit HRP (1:5000) was used as secondary 
antibody. 
 
Generation of PLD YFP fusion constructs 
The plasmid encoding human PLD1 and mouse PLD2 were kindly provided by 
Dr. Michael Frohman. DNA encoding full length PLD1 and PLD2 were sub-
cloned into pMEYFPzeo-C1 vector by Dr. Nagendra Singh. Deletion mutants of 
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PLD1 and PLD2 in pMEYFPzeo-C1 were constructed using convenient 
restriction sites or polymerase chain reaction-based strategies and were 
sequenced at all junctions to ensure that the reading frame was maintained. 
Plasmids were sequenced to confirm the intended mutation. The mutant 
constructs of both PLD1 and PLD2 were confirmed to be expressed at similar 
levels and at the expected sizes (Fig 5 and 6). Primers used for the generation of 
the constructs are listed in Table 1. 
 
Confocal microscopy 
Jurkat T antigen cells were transfected with the PLD YFP fusion constructs by 
electroporation. Live cells were isolated (16-18 hrs after transfection,) using 
lymphocyte separation medium (Mediatech, Inc). Approximately 105 cells in 50μl 
medium were spread on 0.1% lysine coated glass slides. The cells were left to 
adhere to the glass slide for 5 mins and the excess medium was drained. Cells 
were fixed with 4% Paraformaldehyde for 10-20 mins and washed with 1x PBS 
for three times. For nuclear staining, DAPI (Molecular probes) or Propidium 
iodide was added to cells for 5 mins and washed with 1x PBS three times. One 
drop of prolong antifade (Molecular probes) was added on top of the cells and 
mounted with cover slip. Slides were left overnight at room temperature in the 
dark and analyzed using Zeiss® LSM-510 laser scanning microscope at the 
LUMC and MCG core imaging facility. LSM image examiner software was used 
for image acquisition and analysis. 
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Fig 5. Western blot analysis of PLD1 deletion mutant constructs. Full length 
and deletion mutant constructs of hPLD1b were transfected into Jurkat T antigen 
cells by electroporation. The following day live cells were isolated and lysed in 
1xSDS sample buffer. A) Proteins were separated on 8% polyacrylamide gel and 
probed with anti-GFP antibody. B) Proteins were separated on 12% 
polyacrylamide gel and probed with anti-GFP antibody. Protein markers sizes 
(kDa) are indicated on the left side of the gel. Protein of expected size was 
obtained for the different constructs. Vector only: 30   kDa, Full length PLD1: 150 
kDa, loop deleted PLD1: 130 kDa, PH+PX+C: 75 kDa, PH + PX only: 62 kDa, N-
terminal deletion: 100 kDa, C-terminal only: 40 kDa. 
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Fig 6. Western blot analysis of PLD2 deletion mutant constructs. Full length 
and deletion mutant constructs of mPLD2 were transfected into Jurkat T antigen 
cells by electroporation. The following day live cells were isolated and lysed in 1x 
SDS sample buffer. Proteins were separated on 8% polyacrylamide gel and 
probed with anti-GFP antibody. Protein markers sizes (kDa) are indicated on the 
left side of the gel. Protein of expected size was obtained for the different 
constructs. Full length PLD2: 125 kDa, PH+PX+C: 75 kDa, C-terminal only: 40 
kDa. 
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In contrast to the diffuse cytoplasm and nuclear localization of YFP-vector 
alone, PLD1YFP and PLD2YFP have peri-nuclear and plasma membrane 
localization respectively (Fig 7). 
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Vector PLD1 PLD2 
 
 
 
 
 
 
Fig 7. Confocal microscopic analysis of YFP fusion constructs. YFP fusion 
(green) construct of vector alone, full length PLD1 and PLD2 were transfected in 
Jurkat T antigen cell line. The sub cellular localization of these constructs was 
determined using confocal microscopy. 
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G TGG GCT CAC CAT GAG - 3'
6 5'- TAT CAC ATG GAC GTA AGC GGC GT -3'
7 hPLD1b (PX+PH+C) 5'- CTC AAA GAT CAT CGA TTT GGG TCA 
    GTT GTC CTT GGC TAT CTT GAT GAC - 3'
 
Table 1. PCR primers 
 
 
 T TA
 
Number Primer Name Sequence
1 hPLD1b ( PX+PH only) 5'- GGC CGC GAT ATC TCA CTA A - 3'
2 5'- TA
 
 
  
 
 T TT
G TGA GAT ATC GC- 3'
3 hPLD1b ( loop deletion) 5'- TAA ACT ACG GAT GGA CCC GGT 
    AGT GAC CCG CTT CAC ACT - 3'
4 5'- AGT GTG AAG CGG GTC ACT ACC GGG
     TCC ATC CGT AGT TTA - 3'
5 5'- TA
 
 
 
 
 
 
 
 
 
 
 
 
 
8 5'- TTC AAA ATT AAG GTG GGG AAG - 3'
9 hPLD1b (C terminal only) 5'- GGA TAT TCA TGC GGC CGC TCA TTA 
    AGT CCA AAC CTC CAT GGG - 3'
10 5'- TTT AGG CTC GAG CTG TTG TCC TTG 
    GCT ATC TTG AT - 3'
11 mPLD2 (PX+PH+C) 5'- CTA CAG CTA CAT CAG CAT GAC AGC
    GTG ATT CTT GGG GCA AAT ACC TGG - 3'
12 5'- TCC CTG ATT CTC AAA TGC AGC AGC -3'
13 5'- TTC ACC TTC TGT GGC CGA GAC C - 3'
14 5'- CCA GGT ATT TGC CCC AAG AAT CAC 
    GCT GTC ATG CTG ATG TAG CTG TAG - 3'
 
 
 
15 mPLD2 (C terminal only) 5'- AAG GAC TCC TTC CTG CTG TAC ATG - 3'
16 5'- TTC AGT CTC GAG CTG TGA TTC TTG 
    GGG CAA ATA CC- 3'
 
 
 
 
PLD2 (- / -) mice genotyping primers
17 P274 5'- GCC ATC TCA TTT GTT CAG CTT T - 3'
18 P275 5'- GCT GTC ATG CTG ATG TAG CTG T - 3'
19 CD4 CRE FWD 5'- CGA TGC AAC GAG TGA TGA GG - 3'
20 CD4 CRE REV 5'- GCA TTG CTG TCA CTT GGT CGT - 3'
21 FLP FWD 5'- CAC TGA TAT TGT AAG TAG TTT GC- 3'
22 FLP REV 5'- CTA GTG CGA AGT AGT GAT CAG G - 3'
                                                                                                                                                            
                                                                                                                                         
CHAPTER THREE 
EXPERIMENTAL RESULTS 
 
REGULATION OF PHOSPHOLIPASE D SIGNALING BY EXOGENOUS 
FACTORS 
Antigen stimulation of lymphocytes results in increased PLD activity. 
Primary alcohol is a well-known inhibitor of PLD signaling. Previous studies have 
documented the inhibition of T cell activation in the presence of primary alcohols 
in vitro. Singh et al (Singh et al., 2006) analyzed the effect of inhibiting PLD 
signaling in different subsets of CD4 T cells using 0.3% 1-butanol. Inhibition of 
PLD signaling selectively blocked the proliferation of CD4+CD25- (effector) T 
cells and led to the enrichment of Foxp3+ regulatory T cells. This study 
highlighted the differential requirement for PLD signaling among effector versus 
regulatory T cell subsets. 
We then sought to determine the role of PLD signaling in dictating the 
immune response of the host.  We hypothesized that in vivo suppression of PLD 
signaling may promote immune suppression through dominance of Treg cells 
under physiological/pathological conditions. Conversely, enhancement of PLD 
signaling under certain conditions might promote dominance of effector T cells 
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and thus promote immune reactivity. For my studies, I focused on identifying 
various exogenous and endogenous factors that alter the immune status of the 
host through modulating PLD signaling.  
 
Ethanol and CD4 T cell population dynamics 
Based on the effect of 1-butanol, we predicted that another 1-alcohol, 
ethanol would also inhibit PLD signaling. Ethanol is widely consumed for 
recreational purposes and is considered as an immunosuppressive agent (Cook, 
1998; Nelson and Kolls, 2002; Zhang and Meadows, 2005).  Excessive alcohol 
intake has been associated with increased incidence of infection, cancer and 
autoimmunity (Song et al., 2002). Previous studies in mice indicate that alcohol 
administration for short duration causes reduced cell numbers of immune cells 
like T cell, B cell and NK cells and concomitant reduction in the cellularity of 
spleen and thymus (Chadha et al., 1991). However, the effect of alcohol on CD4 
T cells in specific and the mode of action were not delineated.  
To determine if ethanol can enrich for Treg cells, we treated murine CD4 T 
cells with varying concentrations of ethanol in the presence of anti-CD3 
stimulation in vitro for 4 days. After 72 hrs of stimulation, cells were washed and 
cultured for 3 days in the presence of IL-2.  Cells were harvested and stained for 
regulatory T cell markers, Foxp3 and CTLA4.  When T cells were stimulated by 
anti-CD3 antibody in the presence of low concentrations of alcohol (0.5%), no 
enrichment of Foxp3+ Treg cells was observed and the frequency of Foxp3+  
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Figure 8.  Effect of ethanol on CD4 T cells in vitro. Total CD4+ T cells were 
cultured with anti-CD3 plus antigen presenting cells in medium containing 
increasing concentrations (0.5% - 2%) ethanol for 3 days. After 3 days, cells 
were placed in medium containing IL-2 (20ng/ml) for 4 days. Seven days after 
the start of culture, cells were harvested and analyzed by flow cytometry for 
Foxp3 and CTLA4 expression. Representative data from 3 independent 
experiments is shown. 
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cells was similar to medium-treated samples.  When higher doses of ethanol 
were used (1.0%, 2.0%), however, we observed a clear dose dependent 
increase in Treg frequency (Fig 8) among CD4 T cells and observed 4.9 and 
16.5% of CD4 T cells becoming Foxp3+, respectively.  Similar to 1-butanol, CD4 
T cells expanded in the presence of 2% ethanol contain higher percentages of 
Foxp3+ cells. 
The experiment shown above used stimulation of T cells by anti-CD3 
antibodies. To determine if ethanol can enrich for antigen specific Treg cells, we 
next tested the effect of ethanol on antigen-induced T cell proliferation using CD4 
T cells from P25 TCR transgenic mice. The P25 mouse carries a transgene 
encoding the TCR specific for peptide-25 of Mycobaterium tuberculosis (Tamura 
et al., 2004). T cells were stimulated with the antigen peptide in the presence of 
irradiated antigen presenting cells for 3 days followed by culture in the presence 
of IL-2 for 4 days. Similar to anti-CD3 stimulated cultures, the frequency of 
Foxp3+ cells in 2% ethanol treated cultures were 22% as against 0.6% in both 
medium and 0.5% ethanol treated samples (Fig 9).    
The increase in percentage of Foxp3+ cells could be due to increased 
proliferation of Foxp3+ cells in 2% ethanol treated cultures or due to decreased 
proliferation of Foxp3- T cells. To test for these possibilities, we labeled CD4 T 
cells with CFSE and measured the dilution of CFSE to monitor proliferation. 
Compared to 0.5% ethanol, very few Foxp3- T cells proliferated in 2% ethanol 
treated cultures as seen from the CFSE dilution plots (Fig 10).  
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Figure 9. Effect of ethanol on CD4 T cells in the presence of antigenic 
stimulation in vitro. Total CD4+ T cells from P25 TCR transgenic mice were 
cultured with P25 peptide (0.1ug/ml) plus antigen presenting cells in medium 
containing different percentages of ethanol for 3 days.  After 3 days, cells were 
placed in medium containing IL-2 (20ng/ml) for 4 days. Seven days after the start 
of culture, cells were harvested and analyzed by flow cytometry for Foxp3 and 
CD25 expression. Representative data from 2 independent experiments is 
shown. 
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Figure 10.  Proliferation kinetics of CFSE labeled CD4 T cells in the 
presence of ethanol. Total CD4+ T cells were labeled with CFSE (2.5ug/ml) and 
cultured with anti-CD3 (0.2ug/ml) and APCs in medium containing 0.5% ethanol 
(solid line) or 2% ethanol (dotted line) for 3 days. Cells were placed in medium 
containing IL-2 (20ng/ml) for next 4 days. On day 7 after stimulation, cells were 
harvested and analyzed by flow cytometry for Foxp3 and CFSE expression. A) 
Line graph depicting number of Foxp3- T cells in different generations B) Line 
graph depicting number of Foxp3+ T cells in different generations.  
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As a result, the total Foxp3- T cell numbers recovered from 0.5% ethanol treated 
cultures were 8 times more than that recovered from 2% ethanol cultures. In 
contrast, Foxp3+ cells from samples treated with 2.0% ethanol showed no 
difference in CFSE levels between 0.5% and 2% ethanol treated samples. 
Together, the data demonstrate that ethanol causes increased frequency of 
Foxp3+ cells by decreasing the proliferation of Foxp3- T cells.  
Epidemiological studies showed that alcohol abusers are predisposed to 
more frequent and more severe infections (Cook, 1998). In particular, increased 
incidence of infections and enhanced severity of disease such as pneumonia and 
tuberculosis were associated with chronic consumption of alcohol (Cortese et al., 
1992; Esposito, 1984; Fernandez-Sola et al., 1995; Friedman et al., 1987; Moss 
et al., 1996; Ruiz et al., 1999; Winterbauer et al., 1969). The incidence of chronic 
Hepatitis C Virus (HCV) infection is also increased in alcohol abusers (Degos, 
1999; Harris et al., 2001; Khan and Yatsuhashi, 2000; Lima et al., 2000; Schiff, 
1999). Also, studies on rodents show that animals are more vulnerable to 
infection after chronic or acute exposure to alcohol. These observations can be 
interpreted based on our in vitro studies in the following manner: Consistent 
intake of alcohol might lead to selective elimination of effector T cells and 
consequent enrichment of regulatory T cells. This in turn might increase the 
susceptibility of the host to various infections. Also, antigenic exposure in the 
presence of alcohol might inhibit the proliferation of antigen specific effector T 
cells thus compromising the overall health of the host.  
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We tested for these possibilities in vivo in mice using two different 
experimental set-ups.  First, the effect of ethanol on CD4 T cell subsets in mice in 
the absence of antigen was determined. Wild type C57BL/6 mice were injected 
with either PBS or 20% ethanol intraperitoneally (i.p) for 7 days. Mice were then 
sacrificed and their spleen and mesenteric lymph nodes were harvested and 
stained for regulatory T cell markers. As expected, spleen of mice treated with 
ethanol contained 23.56% of Foxp3+ cells compared to 17.5% in PBS treated 
mice (Fig 11a). This increase in frequency of Foxp3+ cells was due to significant 
decrease in the total Foxp3- CD4 T cell numbers; no significant change in 
Foxp3+ T cell numbers was observed (Fig 11b). These data confirmed our 
prediction that ethanol selectively eliminates Foxp3- T cells even in the absence 
of antigenic proliferation. 
Secondly, we determined if ethanol inhibits antigen-induced effector T cell 
proliferation while allowing Treg cells to proliferate in vivo, as we observed in 
vitro.  To test the effect of ethanol in vivo, we used the protocol that has been 
previously described by others. Briefly, mice were injected with 2.9g/kg body 
weight ethanol in 20% vol/vol saline intraperitoneally (i.p) (Meadows et al., 1989; 
Obradovic and Meadows, 2002; Song et al., 2002). This dose of ethanol injection 
leads to blood ethanol level of 300mg/dl in 30 minutes. We adoptively transferred 
CFSE labeled CD4 T cells from P25 TCR transgenic mice into C57.BL/6 CD45.1 
recipient mice intravenously. These recipient mice express CD45.1 isoform, 
which is distinguishable from the CD45.2 isoform expressed by the donor mice.   
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Figure 11. Flow cytometry analysis and quantification of cell numbers of 
CD4 T cells in mice injected with ethanol. Wild type mice were injected 
intraperitoneally with either PBS or 20% ethanol for 7 days. On day 7, mice were 
sacrificed and their spleen cells were stained for Foxp3, CD4 and CTLA4. A) 
Representative FACS plots of spleen CD4 T cells from PBS and ethanol treated 
mice. B) Bar graphs of total Foxp3- T cell numbers in spleen of PBS (white bars) 
and ethanol (black bars) treated mice. C) Bar graphs total Foxp3+ T cell numbers 
in spleen of PBS (white bars) and ethanol (black bars) treated mice. 
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Figure 12. Effect of ethanol on the proliferation kinetics of Foxp3 positive 
and Foxp3 negative CD4 T cells in vivo in the presence of antigen. CFSE 
labeled CD4 T cells from P25 TCR transgenic (Ly5.2) mice were intravenously 
transferred to Ly5.1 recipient mice. 24 hrs later, the recipients were challenged 
with 2.5ug of P25 peptide along with either PBS (control) or 20% ethanol (i.p) for 
a period of 7 days. On day 8, mice were sacrificed and all their peripheral lymph 
nodes (axial, cervical, inguinal, popliteal) were isolated and pooled for analysis 
by flow cytometry. A) Representative FACS plots showing CFSE dilution in 
lymphocytes of control and ethanol treated mice. B) Line graphs depicting the 
number of foxp3- T cells in each generation of control (dotted lines) and ethanol 
treated (solid lines) mice. C) Line graphs depicting the number of foxp3+ T cells 
in each generation of control (dotted lines) and ethanol treated (solid lines) mice. 
Data is representative of 2 independent experiments. 
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One day after injection of T cells the recipient mice were injected with the antigen 
peptide. Immediately after injection of peptide, mice received ethanol injection as 
described above.  Mice were administered ethanol daily for 7 days.  On day 8, 
mice were euthanized and spleen, mesentric and peripheral lymph nodes 
(inguinal, brachial, axial, popliteal, cervical) were harvested. The state of 
proliferation of adoptively transferred T cells was determined by analyzing the 
CFSE level of CD45.2+ T cells (Fig. 12a). T cells of mice that received no antigen 
showed no proliferation after 7 days while T cells from mice that received antigen 
peptide in PBS showed significant level of proliferation in both Foxp3+ and 
Foxp3- populations.  The frequency of Foxp3+ T cells in PBS treated mice was 
3.5%. Mice injected with ethanol showed a marked reduction in proliferation of 
Foxp3- T cells and the frequency of Foxp3+ T cells was 9.75%. The majority of 
Foxp3- T cells in control mice were in between generation 3 to generation 6 (i.e. 
most of these cells underwent 3 cell divisions)(Fig 12b).  However, there was no 
clear peak in the cell division of Foxp3- T cells of ethanol treated mice suggesting 
that majority of cells did not proliferate effectively. In stark contrast, the level of 
cell division of Foxp3+ cells was comparable between ethanol treated and PBS 
treated mice (Fig 12c). As a consequence, the total cell numbers that were 
obtained from ethanol treated and untreated mice were comparable for Foxp3+ T 
cells but the cell numbers was significantly lower in ethanol treated animals for 
Foxp3- cells.  Together, the data demonstrate that ethanol does block antigen 
induced Foxp3- effector T cell proliferation while allowing Treg cells to expand in 
vivo. 
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Figure 13. Effect of ethanol on homeostatic proliferation of CD4 T cells. 
CD4 T cells from wild type mice were intravenously transferred into RAG1 KO 
mice along with intraperitoneal injections of either PBS or 20% ethanol for 5 
days. On day 6, mice were sacrificed and their spleen cells were stained for 
Foxp3 and CD4 T cells. A) Representative FACS plots of PBS and two ethanol 
treated mice showing CFSE dilution in spleen CD4 T cells. B) Bar graphs of total 
cell numbers of CD4 T cells in the spleen. C) Bar graphs depicting the number of 
foxp3- T cells in each of control (white bars) and ethanol treated mice (filled 
bars). D) Bar graphs depicting the number of foxp3+ T cells in each of control 
(white bars) and ethanol treated mice (filled bars). 
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Zhang et al reported that chronic alcohol consumption (2 weeks-6 months) 
results in T cell lymphopenia, which in turn induces homeostatic proliferation 
(Zhang and Meadows, 2005). Since we also observed similar reduction in cell 
numbers in mice injected with ethanol for 1 week (Fig 11b), we investigated 
whether ethanol affects homeostatic proliferation. We tested the primary effect of 
ethanol on the proliferation of CD4 T cells under well-established homeostatic 
condition like RAG1 KO mice. We adoptively transferred CFSE labeled CD4 T 
cells from wild type mice into RAG-1 knock out mice intravenously followed by 
ethanol injection for 5 days. Under lymphopenic conditions, T cells are stimulated 
by self-peptide and self-MHC (Zhang and Meadows, 2005). We monitored 
proliferation of T cells based on dilution of CFSE.  As seen in (Fig 13b), the total 
CD4 T cell counts in ethanol injected mice were 5 times lower than PBS injected 
mice. Unlike antigen-induced proliferation of CD4 T cells, we did not observe 
selective decrease in Foxp3- T cells alone. Both Foxp3- and Foxp3+ T cells 
counts were reduced by injection of ethanol (Fig 13 c). Thus, the data show that 
in acute phase of homeostatic expansion, ethanol inhibits proliferation of both 
Foxp3- and Foxp3+ CD4 T cells. Further experiments could be aimed at looking 
for specific markers of homeostatic proliferation such as expression of CD44 and 
lack of CD69. 
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Effect of alcohol ingestion on the balance between Foxp3+ and Foxp3- CD4 T 
cells 
The data indicate that continuous and high dose exposure of T cells to alcohol 
may induce a relative increase in the frequency of Foxp3+ T cells. Despite the 
minute presence of endogenous ethanol, alcohol consumption by humans is the 
major source of ethanol in the human body (Antoshechkin, 2001). To study the 
effects of in vivo ethanol exposure on CD4 T cells, we fed mice with liquid diet 
containing alcohol. DO11.10 TCR (T cell receptor) transgenic mice (receptor 
specific for ovalbumin (OVA) plus I-Ad) were fed an alcohol-containing nutrient-
supplemented liquid diet (Bio-Serv, NJ) (ethanol concentration was gradually 
increased from 1% to 6.3% w/v every 2 days) or calorie matched control diet for 
10 days (sex-matched 12-week-old male mice, 6 mice per group). Mice were 
euthanized on day 10, and mucosal CD4 T cells were analyzed for expression of 
Foxp3 by flow cytometry. CD4 T cells from the mesenteric lymph nodes of 
alcohol-fed mice showed a moderate but clear increase in Foxp3+ CTLA4+ T 
cells compared to the control group (Fig 14a).  Average frequency of Foxp3+ 
CD4 T cells increased significantly compared to control diet fed animals (Fig 
14b). These results show that continuous presence of ethanol in the diet causes 
relative increase of Foxp3+ T cell in mucosal associated lymphoid organs and 
suggest that continuous alcohol consumption by humans might lead to selective 
enrichment of Treg cells and immune suppression leading to heightened 
susceptibility to opportunistic infections. 
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A) 
B) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 14.  Effect of alcohol containing diet on mice CD4 T cells. Mice were 
fed on liquid diet containing water or varying concentration of ethanol for 10 days. 
Mice were sacrificed on day 10 and their mesenteric lymph node was stained for 
Foxp3 and CTLA4. A) Representative FACS plots of mesenteric lymph node of 
two control and two alcohol fed mice. B) Data from 2 different experiments were 
pooled and the percentage of Foxp3 positive cells in control versus alcohol fed 
mice is shown as a graph. 
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 Clostridium difficile toxin: Hijacking the immune system through PLD 
Clostridium difficile (C.diff) is a spore forming, anaerobic, gram-positive 
bacterium (Genth et al., 2008). Its role in the pathogenesis of 
pseudomembranous colitis is well established. Recently, it has emerged as the 
leading cause of nosocomial diarrhea in patients (Genth et al., 2008). Bacterial 
pathogens interact with the mammalian cells through the production of protein 
toxins (Fiorentini et al., 2003). These toxins serve as virulence factors and aid in 
establishing their niche in the host. The major virulence factors produced by 
C.difficile are Toxin A and Toxin B. Following cell entry, these toxins mono-
glucosylate and thereby inactivate lower molecular mass GTP binding proteins of 
the Rho sub family (Genth et al., 2008). As mentioned previously, PLD is one of 
the downstream effector molecules of Rho. As a consequence, C.difficile toxins 
are considered inhibitors of PLD signaling. 
Thus, we hypothesized that C.difficile might evade the host T cell effector 
response by inhibiting PLD signaling. If these toxins inhibit PLD signaling in T 
cells as well, then we expect to see inhibition of effector T cell proliferation in the 
presence of these toxins. To test the effect of C.difficile toxins on T cell 
proliferation, PKH-26 (analog of CFSE) labeled CD4 T cells were stimulated with 
anti-CD3 in the presence of varying amounts of supernatants from toxigenic and 
non-toxigenic strains of C.difficile (C.difficile supernatants were kindly provided 
by Michelle Merrigan). As seen in (Fig 15a,b), following TCR stimulation 50% of 
both Foxp3+ and Foxp3- T cells had undergone one cell division.  
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C) 
Toxin B concentration (
 
 
 
 
 
 
 
 
 
 
 
 
μg/ml)  
Fig 15. Analysis of proliferation kinetics of Foxp3+ and Foxp3- T cells in the 
presence of C.difficile toxin supernatants. CD4 T cells were labeled with 5μM 
PKH-26 and stimulated with anti-CD3 (0.2ug/ml) and APCs. Varying amounts of 
supernatants from toxigenic (Tcd) or non-toxigenic (non-Tcd) (0.05%-0.25%) 
strains of C.difficile were added to the culture medium. 72 hrs after stimulation, 
cell were harvested and stained with anti-Foxp3 antibody. A) Histograms 
comparing the proliferation of Foxp3- T cells (top row) and Foxp3+ T cells 
(bottom row) between medium (left side) and 0.15% of C.difficile supernatants 
(right side) treated samples.  Left panels: blue line (stimulated sample) and red 
line (unstimulated sample). Right side: blue line (supernatant from toxigenic C.diff 
strain) and red line (supernatant from non-toxigenic C.difficile strain) B) Graph 
showing percentage of growth inhibition between samples containing increasing 
amounts of C.difficile culture supernatants. C) Bar graph showing percentage of 
growth inhibition in Foxp3+ and Foxp3- T cells in the presence of purified TcdB 
(μg/ml). 
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In comparison, the Foxp3- T cell proliferation was decreased substantially 
when the concentration of toxin containing supernatants was increased. Also, we 
observed some inhibition in the proliferation of Foxp3+ T cells at higher 
concentrations of the toxin supernatants (Fig 15b). Since we used supernatants 
from C.difficile cultures as the source of toxin, it is possible that components 
other than toxins might exhibit non-specific effects at high concentrations.  
Further, to confirm that toxins specifically mediate the effect on T cell 
proliferation, we performed this experiment with purified Toxin B. Purified toxin B 
(1ug/ml) inhibited the proliferation of Foxp3- T cells by 60% while inhibition of 
proliferation of Foxp3+ T cells was 10% (Fig 15c). These results suggest that 
C.difficile toxin B (TcdB) through inhibiting PLD signaling blocks effector T cell 
proliferation significantly. 
 Why does inhibiting PLD signaling selectively affect the proliferation of 
Foxp3- (effector) T cells? In our studies with 1-butanol, we showed that PLD 
signal inhibition abrogates activation induced expression of CD25 on Foxp3- 
(effector) T cells. In contrast, Foxp3+ Treg cells express CD25 constitutively. 
CD25 is IL-2 receptor alpha chain, up regulated on effector T cells following their 
activation. IL-2 is an important survival/proliferation cytokine for activated T cells.  
To test the effect of C.difficile toxin on the expression of CD25, CD4 T cells were 
stimulated with anti-CD3 both in the presence and absence of toxin containing 
supernatants. CD25 expression on these samples was determined 24 hrs after 
stimulation. Stimulation of T cells resulted in significant up regulation of CD25 
and CD69 in medium or non-toxigenic supernatant containing samples (Fig 16).  
                                                                                                                                                 
                           
86
                                                                         
                                                                        
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 16. Flow cytometric analysis of activation markers expressed by 
CD4 T cells following antigenic stimulation in the presence of C.difficile 
supernatants. CD4 T cells were stimulated with anti-CD3 and APCs. Equal 
amounts (0.15%) of culture supernatants from either toxigenic or non-toxigenic 
C.difficile strains were added. 24 hrs after stimulation, cells were harvested, 
stained for activation markers, CD25 and CD69 and analyzed by flow cytometry. 
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In contrast, the expression of CD25 was not increased in samples treated with 
toxin containing supernatants. This result is in agreement with our previous 
finding that inhibition of PLD signal blocks CD25 up regulation. Future 
experiments can be performed to determine if C.difficile toxin B specifically 
inhibits CD25 expression on Foxp3- T cells. 
 Based on our data on alcohol diet fed mice, we predicted that mice 
exposed to C. difficile toxin/spores would have increased frequency of Treg cells. 
To test this possibility, we analyzed the frequency of Foxp3+ T cells in mice 
infected with C. difficile spores. Treatment with antibiotics disrupts the normal 
commensal microbiota in the host intestine and is often associated with 
increased incidence of Clostridium Difficile- associated diarrhoea (CDAD) (Giel et 
al., 2010; Vollaard and Clasener, 1994). Based on these studies, mice were 
treated with various antibiotics prior to introduction of C. difficile spores to induce 
CDAD. Mice were treated with antibiotics and infected with C. difficile spores by 
Pehga Mohseni. Compared to wild type mice, mesenteric lymph nodes of mice 
colonized with C. difficile had higher percentages of Foxp3+ T cells (Fig 17 a). As 
expected, this increase in Foxp3+ percentage was due to concomitant decrease 
in Foxp3- T cell numbers (Fig 17b). However, a potential caveat of this 
experiment is the absence of mice injected with spores derived from non-
toxigenic strain of C. difficile as a negative control. It is possible that the stringent 
treatment with antibiotics might have contributed to the increased frequency of 
Treg cells. Future experiments could be aimed at comparing mice colonized with 
spores from both toxigenic and non-toxigenic strains.  
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Fig 17. Flow cytometric analysis of Foxp3+ T cell percentage in mice 
infected with C. difficile spores. C57BL/6 mice were treated with broad-
spectrum antibiotics for 72 hrs. For the next 48 hrs, these mice were fed normal 
drinking water and injected intraperitonealy with clindamycin. 24 hrs later, these 
mice were given (50,000 CFU) C. difficile spores by oral gavage. 72 hrs later 
these mice were sacrificed and their mesenteric lymph nodes were harvested 
and stained using anti-CD4 and Foxp3 antibodies. A) FACS plots from wild type 
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mice (WT) and two different mice infected with C. difficile spores showing the 
percentage of CD4 T cells expressing Foxp3. B) Bar graph of Foxp3- T cell 
numbers in wild type and C. difficile spores-infected mice. C) Bar graph of 
Foxp3+ T cell numbers in wild type and C. difficile spores-infected mice. 
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Nevertheless, based on evidence from other models of PLD signal inhibition, it is 
tempting to speculate that exposure to C. difficile toxins might lead to preferential 
enrichment of Treg cells in vivo. 
 
REGULATION OF PHOSPHOLIPASE D SIGNALING BY NATURALLY 
PRESENT ENDOGENOUS FACTORS 
Adenosine (Ado) is an endogenous molecule that mediates a wide 
spectrum of biologic effects by engaging 4 kinds of cell surface receptors: A1, 
A2a, A2b and A3. Ado is found in very high concentrations under hypoxic 
conditions like tissues surrounding inflammatory sites and tumors. Notably, these 
Ado rich environments have an immune suppressive phenotype. For example, 
increased frequency of Treg cells has been reported in most human solid tumors 
(Beyer and Schultze, 2006). Several reports highlight the immune modulatory 
effects of Ado acting through A2a receptor on T cells. However, there is little 
experimental evidence for a role of A3 receptors mediating effects of Ado in T 
cells. Interestingly, both A2a and A3 receptors have been previously reported to 
modulate cell functions through regulating PLD activity.  We hypothesized that 
one mechanism by which adenosine can decrease immune responsiveness is 
through inhibiting PLD signaling.  
TCR stimulation has been shown to modulate the expression of adenosine 
receptors in mice (Lappas et al., 2005) and humans (Gessi et al., 2004b). To 
understand the role of adenosine A3 receptor signaling on T cell activation, we 
investigated the kinetics of A3 receptor expression on CD4+CD25+ regulatory T 
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cells (Treg cells) and CD4+CD25- T cells (non-Treg cells) under resting and 
activated conditions. We purified CD4+CD25- and CD4+CD25+ T cells from 
C57.BL/6 mouse splenocytes and stimulated them with anti-CD3 and anti-CD28 
antibodies.  Total cell lysates from each group of T cells were separated by SDS-
PAGE and analyzed by Western blot for expression of the A3 receptor. Under 
resting conditions, freshly isolated CD4+CD25- T cells did not express detectable 
level of adenosine A3 receptor while CD4+CD25+ T cells expressed barely 
detectable levels of the receptor. However, following stimulation both 
CD4+CD25+ and CD4+CD25- T cells express comparable levels of adenosine A3 
receptor (Fig 18).  
We then examined the functional relevance of A3 receptor expression on 
CD4 T cells using adenosine A3 receptor selective agonist, AB-MECA. We 
stimulated splenic CD4 T cells with anti-CD3 antibody plus irradiated T-depleted 
splenocytes (APCs) in the presence or absence of AB-MECA. We first examined 
the effect of AB-MECA on the expression of early activation markers on T cells 
namely CD69 and CD25 (IL-2 receptor α chain) following 24 hrs of stimulation. 
Under these conditions, 65% of stimulated T cells expressed both CD25 and 
CD69 whereas CD69 and CD25 alone were expressed by 5% and 13% 
respectively (Fig 19a). In contrast, in cultures treated with AB-MECA, the 
frequency of CD69+CD25+ T cells decreased to 40% and CD25 alone increased 
to 21% and we observed little effect on CD25+CD69- T cells as the frequency 
remained at 5%. Since naturally occurring regulatory T cells (nTreg cells) 
constitutively express CD25 and non-Treg (CD4+CD425-) T cells express CD25  
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Fig 18. Western blot analysis of adenosine A3 receptor expression on CD4 
T cells. Treg cells (CD4+CD25+) and non-Treg (CD4+CD25-) T cells were 
sorted from wild type mice by flow cytometry. Lysates of unstimulated versus 
stimulated T cells were separated on 8% polyacrylamide gel, transferred onto 
nitrocellulose membrane and blotted with antibody against A3 receptor 
(66kDa)(Top blot). Molecular weights are indicated on the left side of the blot. 
The membrane was stripped and probed with antibody against β-actin as loading 
control (bottom row). 
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Fig 19. Analysis of activation markers on T cells following antigenic 
stimulation in the presence of A3 receptor signaling. CD4 T cells or 
CD4+CD25- T cells were stimulated with anti-CD3 (0.2ug/ml) and T cell depleted 
splenocytes (APCs) for 24 hrs in the presence of DMSO or AB-MECA. T cells 
were stained with anti-CD25, anti-CD69 and analyzed by flow cytometry. A) Dot 
plots of CD4 T cells expressing CD25 and CD69. B) Histograms of CD4+ CD25- 
T cells expressing CD25 after TCR stimulation. Shaded peaks represent 
unstimulated controls and solid black lines denote activation induced up -
regulation of CD25. 
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only upon activation, we sorted Treg cells and non-Treg cells and determined the 
expression of CD25. 70% of non-Treg cells in control cultures were CD25 
positive in comparison to 45% in AB-MECA treated cultures (Fig 19 b). These 
data collectively indicate that AB-MECA inhibits the expression of CD25 on non-
Treg cells and has no effect on Treg cells as they constitutively express CD25. 
Next, we examined the effect of AB-MECA on CD4 T cell proliferation at 
72 hrs post stimulation (Fig 20a). In the presence of AB-MECA, there was 
approximately 3-fold reduction in the proliferation of CD4 T cells.  A similar 
inhibitory effect of AB-MECA was observed even in the presence of exogenous 
IL-2 consistent with the reduced expression of CD25 (IL-2 receptor α chain) (Fig 
20b).  Also, we measured cytokine secretion by CD4 T cells both in the presence 
and absence of AB-MECA. For this experiment, purified CD4 T cells were 
stimulated with plate-bound anti-CD3 antibody plus soluble anti-CD28 antibody.  
After 24~72 hours of stimulation, culture supernatant was collected and analyzed 
by ELISA (Fig 20c).  Stimulation of CD4 T cells under these conditions induced 
substantial amount of IL-2, IFN-γ, and IL-4 and the level of cytokines in the 
supernatant continued to increase for 72 hours. When AB-MECA was present, 
the initial 24 hours of cytokine production was not significantly affected.  
However, the level of cytokine production in AB-MECA treated samples showed 
profound reduction compared to the control samples at later time points (48 and 
72 hrs). Among the cytokines examined, IFNγ and IL-4 production were severely 
reduced, potentially due to inhibition of proliferation of activated T cells.  
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Fig 20.  Comparison of proliferation and cytokine secretion profile of DMSO 
and AB-MECA treated CD4 T cells. A) CD4 T cells were stimulated anti-CD3 
(0.2ug/ml) and APCs in the presence of DMSO or AB-MECA (50uM) for 72 hrs. 
Cells were harvested and proliferation was measured using cell titer glo kit 
(Molecular probes). (A) in the absence of IL-2 (B) in the presence of IL-2 
(20ng/ml) C) CD4 T cells were stimulated with plate bound anti-CD3 (2ug/ml) and 
anti-CD28 (1ug/ml). Supernatants were collected at different time points and 
analyzed using ELISA. 
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 Adenosine and CD4 T cell population dynamics 
In addition to determining the effect of A3 receptor signaling on the effector 
functions of CD4 T cells, we investigated the effect of A3 receptor signaling on 
CD4 T population dynamics. Based on the previous observation of inhibition of 
CD25 expression on non-Treg cells by AB-MECA, we predicted that culture of 
CD4 T cells with exogenous IL-2 and AB-MECA would cause preferential 
enrichment of Treg cells. To test this hypothesis, CD4 T cells were stimulated 
with anti-CD3 in the presence of DMSO or AB-MECA for 3 days followed by 
expansion in IL-2 containing medium for 3 days. The culture medium was 
supplemented with fresh AB-MECA and anti-CD3 every 24 hrs for the first 3 
days. As predicted, flow cytometry showed 22% of CD4 T cells were Foxp3 and 
CTLA4+ in AB-MECA treated samples in contrast to <2% in DMSO treated 
samples (Fig 21 a).  
The increased percentage of Foxp3+ CD4 T cells in AB-MECA treated 
cultures could result from either expansion of Foxp3+ T cells or from induction of 
Foxp3 expression in CD4+CD25- T cells. To test for the possibility of increased 
expansion of Foxp3+ cells, we tested the effect of AB-MECA on the proliferation 
of CD4+CD25- and CD4+CD25+ T cells separately. AB-MECA substantially 
reduced the proliferation of CD4+CD25- T cells (50% reduction) and had no 
significant effect on the proliferation of CD4+CD25+ T cells (Fig 21b).  This result 
of inhibition of CD4+CD25- T cell proliferation was confirmed using CFSE 
proliferation assay as well. 
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Fig 21. Effect of adenosine A3 receptor signaling on CD4 T cell population 
dynamics. A) Total CD4 T cells were cultured with anti-CD3 antibody plus APCs 
in medium containing DMSO or adenosine A3 receptor specific agonist (AB-
MECA, 50uM) for 72 hrs. After 3 days, cells were placed in medium containing 
IL-2 (20ng/ml) for 4 days and analyzed for Foxp3 and CTLA4 expression. B) 
CD4+CD25- and CD4+ CD25+ T cells were sorted from mice splenocytes and 
cultured with anti-CD3 and APCs along with DMSO or AB-MECA for 72 hrs. 
Proliferation was assessed using cell titer glo kit (Molecular probes). 
                                                                                                                                                 
                           
99
                                                                         
                                                                        
 
 
Relative increase in Foxp3+ T cells with AB-MECA could also be caused 
by de novo induction of Foxp3+ cells from naïve T cells (Chen et al., 2003). To 
address this possibility, CD4+CD25- T cells were stimulated with anti-CD3 in the 
presence or absence of AB-MECA. TGF-beta has been shown previously to 
induce Foxp3 expression in CD4+ CD25- T cells and thus served as positive 
control for this experiment. However, similar treatment of naïve T cells with AB-
MECA did not lead to induction of Foxp3+ expression in CD4 T cells (Fig 22, top 
row). Interestingly, co-culture of AB-MECA with TGF-β led to significant reduction 
in the percentages of Foxp3+ CD4 T cells (8%) compared to 20% of TGF-β alone 
treated cultures (Fig 22, bottom row). This result could mean that A3 receptor 
signaling antagonizes TGF-β signaling in naïve T cells. Taken together, these 
data rule out the possibility of Foxp3 induction by AB-MECA and rather strongly 
suggest preferential enrichment of Foxp3+ T cells. 
Next, we asked whether adenosine A3 receptor signaling could inhibit 
effector T cell proliferation in vivo in mice. To address this question, CFSE 
labeled transgenic mouse derived CD4 T cells were intravenously transferred 
into congenic Ly5.1 mice and challenged in vivo with the cognate antigenic 
peptide with or without AB-MECA.  As the source of CD4 T cells, we used p25 
TCR transgenic mouse T cells, specific to Mycobacterium Tuberculosis antigen 
p25 peptide (Tamura et al., 2004). The antigen challenged mice also received 
AB-MECA or vehicle control through intraperitoneal (i.p) injection daily for 1 
week. Expression levels of Foxp3 and CFSE were measured on day 8 after 
antigen administration. 
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Fig 22. Flow cytometric analysis of Foxp3 induction in CD4+CD25- T cells 
following adenosine A3 receptor signaling. CD4+CD25- T cells were cultured 
with anti-CD3 stimulation and APCs in medium containing DMSO or adenosine 
A3 receptor agonist (AB-MECA) for 72 hrs. After day 3, cells were placed in 
medium containing IL-2 (20ng/ml) for 4 days and analyzed for Foxp3 and CTLA4 
expression (Top row). Exogenous TGF-β (5ng/ml) was added to the medium 
(bottom row). 
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Intravenous injection of 2.5μg antigen peptide in the recipient mice caused 
effective proliferation of CD4 T cells as seen from the progressive dilution of 
CFSE in dividing cells (Fig 23a). As expected from in vitro data, CFSE labeled 
CD4 T cells proliferated considerably less in AB-MECA treated mice compared 
vehicle treated control mice. Also, we observed increased frequency of Foxp3+ 
CD4 T cells in AB-MECA treated mice. Further, we compared the total cell 
numbers in each cell division of the Foxp3- and Foxp3+ T cell fraction (Fig 23b). 
Consistent with the in vitro data, we found reduced cell numbers in Foxp3- T cell 
fraction alone of AB-MECA treated mice. This result led us to suggest that A3 
receptor (A3R) signaling selectively inhibits effector T cell proliferation in vivo as 
well. Thus, under adenosine rich conditions (eg: excessive inflammation, hypoxia 
induced cell death in solid tumors), A3R activation might inhibit effector T cell 
proliferation with a concomitant increase in the frequency of Treg cells and 
change the balance towards immune suppression. 
 
Cross talk between Adenosine receptor and Phospholipase D signaling 
  Ado receptors, A2a and A3 have been reported to utilize PLD in mediating 
cell functions (Thibault et al., 2000) (Mozzicato et al., 2004). In light of our 
findings with A3 receptor signaling in CD4 T cells, we next determined the effect 
of A3R signaling on PLD activity in CD4 T cells.  TCR induced PLD activity was 
measured in AB-MECA treated CD4 T cells using a commercially available PLD 
assay kit (Molecular Probes). First, whole splenocytes from P25 TCR transgenic 
mice were stimulated with the cognate P25 peptide overnight to induce the 
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Figure 23. Effect of A3 receptor signaling on the proliferation kinetics of 
Foxp3 positive and Foxp3 negative CD4 T cells in vivo. CFSE labeled CD4 T 
cells from P25 TCR transgenic (Ly5.2) mice were intravenously transferred to 
Ly5.1 recipient mice. 24 hrs later, the recipients were challenged with 2.5ug of 
P25 peptide along with either DMSO (control) or AB-MECA (200ug/Kg) (i.p) for a 
period of 7 days. On Day 8, mice were sacrificed and all their peripheral lymph 
nodes (axial, cervical, inguinal, popliteal) were isolated and pooled for analysis 
by flow cytometry. A) Representative FACS plots showing CFSE dilution of 
adoptively transferred T cells in DMSO and AB-MECA treated mice. B) Line 
graphs depicting the number of foxp3- T cells in each generation of DMSO 
(dotted lines) and AB-MECA treated (solid lines) mice. C) Line graphs depicting 
the number of foxp3+ T cells in each generation of DMSO (dotted lines) and 
ethanol treated (solid lines) mice. Data is representative of 2 independent 
experiments. 
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Fig 24. Assay of PLD activity in AB-MECA treated CD4 T cells. Total 
splenocytes from P25 TCR transgenic mice were incubated overnight with the 
P25 peptide (1ug/ml). Following day, CD4 T cells were sorted and pre-treated 
with DMSO or AB-MECA for 30 mins. Cells were stimulated with soluble biotin 
conjugated anti-CD3 (10ug/ml) and avidin for 30 mins. Lysates were then probed 
for PLD activity as per manufacturers instruction. Filled bars are DMSO treated 
samples and open bars are AB-MECA treated samples. 
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expression of A3 receptor. The following day CD4 T cells were sorted and 
pretreated with AB-MECA for 30 min before restimulation with soluble anti-CD3 
for 30 min. The total cell lysate from these samples were then used for PLD 
assay as per manufacturers instruction. As reported previously, we observed an 
increase in PLD activity in CD4 T cells following stimulation and this increase is 
not seen in samples treated with AB-MECA (Fig 24). Thus, A3 receptor signaling 
in CD4 T cells blocks TCR induced PLD activity. This indicates that the selective 
inhibition of Foxp3- T cell proliferation in AB-MECA treated cells is caused in part 
by blockade of PLD signaling.  
 
 
Adenosine A3 receptor signaling and cAMP 
A3 receptor activation is linked to Gi-mediated inhibition of adenylyl cyclase 
(Gessi et al., 2008). Recent reports indicate that A3 receptors dictate cellular 
responses such as mast cell degranulation in part by decreasing intracellular 
cAMP concentration (Hasko et al., 2008). To determine the effect of A3 receptor 
activation on cAMP levels in CD4 T cells, splenocytes from P25 TCR transgenic 
mice were stimulated with P25 peptide overnight to induce expression of A3 
receptor. On the following day,  CD4 T cells were sorted by MACS column and 
incubated with DMSO or AB-MECA for 30 min. CD4 T cells were then stimulated 
with biotin conjugated anti-CD3 and avidin for 5 mins. Cells were then lysed in 
0.1N HCL and the supernatants were assayed using cAMP-specific ELISA (Fig 
25a).  
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Fig 25. Assay for cAMP levels and activity in CD4 T cells. A) Total 
splenocytes from P25 TCR transgenic mice were incubated overnight with the 
P25 peptide (1ug/ml). On the following day, CD4 T cell were sorted and pre-
treated with DMSO or AB-MECA for 30 mins. Cells were stimulated with soluble 
biotin conjugated anti-CD3 (10ug/ml) and avidin for 5 mins and lysed in 0.1N 
HCL. A) The supernatants were assayed for cAMP levels using cAMP specific 
ELISA. (* p<0.07, # p= 0.065)  B) CD4 T cells were cultured with anti-CD3 and 
APCs along with varying doses of cAMP (1μM to 1mM) for 3 days. Cells were 
further cultured in IL-2 containing medium for 4 days and analyzed by flow 
cytometry. C) Total Foxp3- T cell numbers (left) and Foxp3+ T cell numbers 
(right) in exogenous cAMP treated cultures on day 7. 
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We did not observe any increase in cAMP levels in either stimulated or non-
stimulated cells of control (DMSO) treated samples. In contrast, we detected high 
concentration of cAMP in both unstimulated and stimulated samples treated with 
AB-MECA. This observation is in stark contrast to what has been reported in 
other immune cells regarding A3 receptors decreasing intracellular cAMP 
concentrations (Jin et al., 1997).  
The second messenger cAMP is shown to be a negative regulator of T cell 
activation and proliferation (Bopp et al., 2007; Ramstad et al., 2000). A previous 
study showed that cAMP-dependent signal transduction interferes with CD25 
expression and IL-2 production (Ramstad et al., 2000). To test if A3 receptor 
signaling blocks effector T cell activation/proliferation via cAMP, CD4 T cell 
proliferation was determined following addition of exogenous cAMP (dibutyryl-
cAMP, Db-cAMP, a cell permeable analog of cAMP, Calbiochem). Total CD4 T 
cells were stimulated with anti-CD3 antibody and APCs in the presence of 
increasing concentrations of Db-cAMP for 3 days followed by culture in IL-2 
containing medium for 4 days. Flow cytometric analysis of Foxp3 and CTLA4 
expression show that low concentrations (1uM-10uM) of cAMP have no effect of 
CD4 T cells population dynamics, whereas high concentration (100-1000μM) 
cause increased frequency of Treg cells (Fig 25 b, c). Hence, increase in cAMP 
level selectively causes inhibition of Foxp3- T cell proliferation similar to those 
observed with AB-MECA. Taken together, these findings indicate that cAMP is 
involved in mediating the effects of adenosine A3 receptor on CD4 T cells. 
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Various studies suggest that the effect of cAMP in T cells is mediated by 
the cytosolic cAMP-dependent protein kinase A (PKA) type I (Ramstad et al., 
2000). It is reported that cAMP binds to the two regulatory subunits in the inactive 
PKA tetrameric holoenzyme to release two active catalytic subunits. In turn, 
these catalytic subunits phosphorylate diverse proteins to regulate their activity 
(Yao et al., 2002). Based on these observations, it was hypothesized that the 
increase in cAMP levels in A3R agonist treated samples would lead to activation 
of PKA followed by increased phosphorylation of its downstream effector 
molecules. To test this experimentally, western blot analysis was performed on 
CD4 T cells stimulated with anti-CD3 in the presence of AB-MECA. The lysates 
were assayed for phosphorylation patterns by western blot analysis using anti-
phospho-PKA substrate antibody. In comparison to both unstimulated and 
stimulated control (DMSO) treated samples, stimulated AB-MECA treated 
samples showed increased phosphorylation of PKA substrates (Fig 26a). cAMP 
assay showed increased cAMP levels in both unstimulated and stimulated 
samples treated with AB-MECA. We further determined the effect of A3 receptor 
signaling on PKA activity in both stimulated and unstimulated T cells. As 
predicted from the data on cAMP, AB-MECA increased PKA substrate 
phosphorylation in unstimulated AB-MECA treated CD4 T cells (Fig 26b). A mild 
increase in PKA substrate phosphorylation was observed in AB-MECA treated 
CD4 T cells stimulated with anti-CD3.  
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Fig 26. Western blot analysis of phosphorylation patterns of PKA 
substrates in AB-MECA treated CD4 T cells. Total splenocytes from P25 TCR 
transgenic mice were incubated overnight with the P25 peptide (1ug/ml). The 
following day, CD4 T cell were sorted and pre-treated with DMSO or AB-MECA 
for 30 mins. Cells were stimulated with soluble biotin conjugated anti-CD3 
(10ug/ml) and avidin for 5 mins and the lysate were separated on 8% 
polyacrylamide gels, transferred on to nitrocellulose membrane and blotted with 
antibody against phospho-PKA substrates. A and B) (Top blot) phosphoPKA blot, 
(bottom) beta actin, loading control. US = Unstimulated sample, S = Stimulated 
sample. 
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In conclusion, these data indicate that adenosine signaling through A3 
receptor blocks T cell proliferation via an increase in cAMP and decrease in PLD 
signaling. 
 
PLD signaling: synergy between ethanol and adenosine 
Since both ethanol and adenosine A3 receptor agonist inhibit PLD activity 
and result in enrichment of Treg cells, we examined if there is synergy between 
the A3R agonist (AB-MECA) and ethanol. CD4 T cells from mouse spleen were 
stimulated with anti-CD3 antibody both in the presence and absence of ethanol 
and AB-MECA. Lower concentrations of ethanol (0.5%) alone did not cause 
increased frequency of Treg cells. However, when 0.5% ethanol was combined 
with 50μM AB-MECA, substantial increase in the percentage of Foxp3+ T cells 
was observed (Fig 27 a). Also, the comparison of Foxp3+ and Foxp3-T cell 
numbers indicate decreased proliferation of Foxp3- T cells in cultures treated 
with either AB-MECA alone or AB-MECA and 0.5% ethanol (Fig 27 b) indicating 
enrichment of Treg cells in these culture conditions. The synergy between these 
two factors may be due to increased suppression of PLD signaling and/or 
inhibition of multiple signaling pathways that collectively block non-Treg 
activation. 
Previously, it was reported that ethanol increases adenosine receptor 
stimulated cAMP levels in human lymphocytes (Hynie et al., 1980) (Gordon et al., 
1986). Increased cAMP levels in the presence of both ethanol and adenosine 
could contribute to the observed synergy in Treg enrichment. However, we  
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Fig 27. Combinatorial effect of ethanol and adenosine on CD4 T cell 
population dynamics.  Total CD4 T cells were cultured with anti-CD3 and APCs  
along with ethanol alone or in combination with AB-MECA(50uM) for 3 days. 
Cells were further cultured in IL-2 containing medium for 4 days and analyzed by 
flow cytometry. A) Flow cytometric plots depicting Foxp3 in the x-axis and CTLA4 
in the y-axis. B) Total Foxp3- T cell (left) and Foxp3+ (right) T cell numbers in 
0.5% ethanol, AB-MECA and in AB-MECA + 0.5% ethanol treated cultures. 
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Fig 28. Western blot analysis of phosphorylation patterns of PKA 
substrates in CD4 T cells treated with a combination of ethanol and AB-
MECA. Total splenocytes from P25 TCR transgenic mice were incubated 
overnight with the P25 peptide (1μg/ml). Following day, CD4 T cell were sorted 
and pre-treated with ethanol (0.5%) or AB-MECA or both for 30 mins. Cells were 
stimulated with soluble biotin conjugated anti-CD3 (10μg/ml) and avidin for 5 
mins and the lysate were separated on 8% polyacrylamide gels, transferred on to 
nitrocellulose membrane and blotted with antibody against phospho-PKA 
substrates. A) (Top blot) phospho PKA blot, (bottom) beta actin, loading control. 
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observed very little, if any, increase in phosphorylation of PKA substrates in 
samples treated with the combination of AB-MECA (50μM) and 0.5% ethanol 
compared to 0.5% ethanol alone (Fig 28). Since there are many potential bands 
that are not separated by 1D gel analysis, further analysis is needed to determine 
whether ethanol and AB-MECA have synergistic effect on PKA activity. 
 
 
STRUCTURE-FUNCTION ANALYSIS OF PHOSPHOLIPASE D 
 
The data presented above show that various exogenous and endogenous 
factors influences the immune outcome by regulating PLD signaling. However, 
the contribution of PLD to T cell signaling is not clearly understood. As described 
previously, the catalytic action of PLD on phosphatidyl choline (PC) results in the 
formation of phosphatidic acid (PA) and soluble choline. The formation of PA 
constitutes the crucial contribution of PLD to cellular signaling and function. PA is 
an important lipid second messenger that can also be synthesized by several 
other routes and thus the contribution of PLD to the overall mass of PA in cells is 
quite miniscule (Ktistakis et al., 2003). Therefore, PLD is thought to only 
influence the local levels of PA. Thus, delineation of the spatial regulation of PLD 
isoforms in T cells will help us understand its function in T cells. 
As mentioned previously, the two isoforms of PLD localize at different 
locations in the cell. Over expression and epitope tag studies reveal that PLD1 is 
found mainly in punctate structures around perinuclear regions while PLD2 is 
primarily found in the plasma membrane. To determine the region that controls 
the localization of PLD1 and PLD2, a series of mutants of both PLD1 and PLD2 
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were generated. In order to assess the localization of these mutants in the cell, 
these mutants were tagged with YFP in the N-terminal and transfected in Jurkat 
T antigen cells, which express SV40 large T antigen to allow high level of 
expression of transfected genes (Northrop et al., 1993) . After transfection (24 
hrs), live cells were separated using Ficoll gradient, mounted on glass slides 
coated with lysine, fixed and covered with cover slip. These slides were then 
analyzed using confocal microscopy.  
 
Determinants of PLD1 perinuclear localization  
At first, we addressed the region responsible for the differential localization 
of PLD1 and PLD2. The primary sequence of PLD1a revealed the presence of 
116 amino acid ‘loop region’ inserted between catalytic sites II and III (Frohman 
et al., 1999).  Previous studies in which the loop region of PLD1 was deleted 
have reported modest increase in the basal activity of PLD1 (Sung et al., 1999). 
Based on this observation, we hypothesized that deletion of the loop region 
redistributes PLD1 similar to PLD2 and this results in increased catalytic activity 
of PLD1. To test this idea, mutant human PLD1b with loop (aa. 504-585) deletion 
was constructed and its localization was assessed using confocal microscopy. 
The loop deletion mutant of PLD1 lost its ability to localize in punctate structures 
surrounding the nucleus and localized to the plasma membrane, similar to PLD2 
(Fig 29). These data suggested that the loop region is a required component for 
PLD1 localization in vesicular structures. 
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Fig 29. Confocal microscopic analysis of the sub-cellular localization of 
PLD1 loop deletion mutant.  PLD1 and PLD2 full length and loop deletion 
mutant are tagged with YFP. Green indicates the localization of the respective 
construct and red in propidium iodide staining of the nucleus. These constructs 
were transfected in jurkat T antigen cells. LIve cells were isolated 24 hours later 
by ficoll gradient and plated on lysine coated glass slides. Cells were then 
imaged using the confocal microscope and images were processed using LSM 
image examiner software. 
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Fig 30. Confocal microscopic analysis of the sub-cellular localization of 
PLD1 loop region alone or loop region and full length PLD1 combinations.  
PLD1 full length is tagged with YFP. Green indicates the localization of the full-
length PLD1 construct. Loop alone construct was tagged with FLAG.  Blue is the 
DAPI staining of the nucleus. Loop alone construct was detected using anti-
FLAG conjugated with flurochrome. PLD1 and loop construct were transfected in 
jurkat T antigen cells either alone or together. Live cells were isolated 24 hours 
later by ficoll gradient and plated on to lysine coated glass slides. Cells were then 
imaged using the confocal microscope and the images were processed using 
LSM image examiner software. 
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Next, we determined if the loop region is sufficient to determine the 
localization of PLD1 into vesicular structures. Furthermore, if loop interacts with 
unknown target molecules in the cell that dictate the localization of PLD1 then 
expression of the loop alone construct could interfere with PLD1-target molecule  
interaction. Therefore, flag tagged ‘loop alone’ construct was co-transfected with 
YFP fusion full length PLD1. Full length PLD1 localized in punctate structures 
and when co-transfected with the ‘loop alone” construct, there were no 
observable differences in its localization (Fig 30). The loop alone construct was 
mainly detected in the plasma membrane. The data suggest that the loop region 
is required for PLD1 sub-cellular localization in the vesicular structures but loop 
alone (aa 504-585) is not sufficient to create the structure of PLD1 that interacts 
with the cellular target that determines the localization of PLD1. 
Also, we determined the contribution of PX, PH and C-terminal regions to 
the peri-nuclear localization of PLD1 by deletion of the corresponding regions 
from full length PLD1. These constructs were transfected into Jurkat T antigen 
cells and their localization was determined by confocal microscopy. The 
construct lacking PX and PH domain (a.a 1-333 deletion) localized entirely in the 
cytoplasm (Fig 31). The mutant with only PX and PH domain (a.a 1-342) had 
diffuse localization in both nucleus and cytoplasm, similar to vector alone. 
Interestingly, the construct with only the C-terminal (aa. 933 -1036) localized 
entirely in the nucleus. This suggests that the C-terminal (aa-933-1036) has 
nuclear import property. Indeed, PLD1b localization in the nucleus has been 
reported before (Freyberg et al., 2001). 
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Fig 31. Schematic representation of the mutant PLD1 constructs and 
confocal microscopy of their sub-cellular localization.  All the constructs are 
tagged with YFP. Green indicates the localization of these constructs.  Blue is the 
DAPI staining of the nucleus. These constructs were transfected in jurkat T 
antigen cells. Live cells were isolated 24 hours later by ficoll gradient and plated 
on lysine coated glass slides. Cells were then imaged using the confocal 
microscope and images were processed using LSM image examiner software. 
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Together, these data suggest that the interaction of PX, PH domain with the rest 
of PLD1 domains determines the perinuclear localization of PLD1. It is evident 
that interactions between different domains rather than a single domain are key 
to the sub cellular localization of PLD1. 
 
Determinants of PLD2 plasma membrane localization  
PLD2 has strikingly restricted distribution to the plasma membrane. Thus, 
YFP fusion constructs of PLD2 deletion mutants were made to determine the 
domain necessary for its plasma membrane localization. The construct 
containing PX+PH+ C-terminal localized to the cytoplasm (Fig 32). Similar to 
PLD1, 'C-terminal only’ construct of PLD2 localized to the nucleus. This 
observation is in agreement with previous studies indicating highly homologous 
C-termini of both PLD isoforms (Liu et al., 2001). Together, these observations 
suggest that the interaction of PX, PH and C-terminal with the catalytic region 
determines the plasma membrane localization of PLD2.  
Future studies can be aimed at assaying the catalytic activities of both 
PLD1 and PLD2 mutant constructs and its effect of TCR signaling to pinpoint with 
certainty the contribution of PLDs to the functioning of the immune system. 
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Fig 32. Schematic representation of the mutant PLD2 constructs and 
confocal microscopy of their sub-cellular localization.  All the constructs are 
tagged with YFP. Green indicates the localization of these constructs.  Red is the 
propidium iodide staining of the nucleus. These constructs were transfected in 
jurkat T antigen cells. Live cells were isolated 24 hours later by ficoll gradient and 
plated on lysine coated glass slides. Cells were then imaged using the confocal 
microscope and the images were processed using LSM image examiner 
software. 
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EFFECT OF PLD2 GENE DELETION ON T CELL RESPONSES 
 
Delineating the isoform specific contribution of PLD1 and PLD2 would be 
critical to address their role in regulatory T cell enrichment. In order to delineate 
the potential role of PLD2 in regulating the balance between effector and 
regulatory T cell subsets, we generated mice deficient in PLD2 specifically in T 
cells. Mice carrying floxed PLD2 genes were crossed with CD4 CRE mice in 
order to delete the gene in double positive (CD4+CD8+) and CD4 and CD8 
single positive T lymphocytes. PLD2 gene was successfully deleted in CD4 T 
cells as detected by the differential size of DNA segments (WT mice = 6 kb, 
PLD2 +/- = 6 and 5.2kb, PLD2 -/- = 5.2Kb) on southern blots (Fig 33a). 
At first, we characterized PLD2flox/floxCD4cre mice to determine the effect 
of deletion of PLD2 on thymocyte differentiation and peripheral T cell activation. 
The absence of PLD2 had minimal effect on T cell development as determined 
by flow cytometric analysis of thymocytes from WT and PLD2 (+/- and -/-) mice 
(Fig 33B). Also, CD4:CD8 ratios in the spleen were similar between PLD2 (+/-) 
and PLD2 (-/-) mice (Fig 33 C). Based on our previous in vitro findings, we 
expected increased frequency of regulatory T cells in PLD2 knock out mice. 
Surprisingly, deletion of PLD2 did not alter the development of naturally occurring 
CD4+ CD25+ Foxp3+ regulatory T cells (Fig 33D). These observations suggest 
that deleting PLD2 at the double positive stage of T cell development does not 
affect the development of CD4, CD8 and regulatory T cells. 
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Fig 33. Phenotypic analysis of conditional PLD2 deficient mice. A) Southern 
blot analysis of CD4 T cells from WT or PLD2 (+/-), PLD2 (-/-) mice. B) Flow 
cytometric analysis of thymocytes from PLD2 deficient mice. X-axis corresponds 
to CD4 T cells and y-axis corresponds to CD8 T cells. C and D) Flow cytometric 
analysis of splenocytes from PLD2 deficient mice. Foxp3 versus CD25 is gated 
on CD4+ T cells. 
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Next, we determined the functional consequences of TCR induced 
signaling in PLD2 deficient T cells. Sorted CD4 T cells were stimulated with anti-
CD3 and irradiated APCs overnight. Expression of CD69 (very early activation 
antigen) and CD25 (IL-2Rα) was determined by flow cytometry. Both WT and 
PLD2 (-/-) mice up regulated activation markers to the same extent (Fig 34A). 
Concomitant with activation status, both WT and PLD2 (-/-) mice had similar 
proliferation kinetics 72 hrs after activation (Fig 34B). Although, our previous in 
vitro experiments suggested that inhibition of PLD signaling using 1-
alcohol/adenosine blocks proliferation of effector CD4 T cells, proliferation of CD4 
T cells from PLD2 knock out mice did not exhibit any significant differences. This 
result indicates that the ability of PLD2 (-/-) CD4 T cells to initially become 
activated is not affected by their lack of PLD2. 
In addition, we determined the cytokine secretion by CD4 T cells of PLD2 
knock out mice. Sorted CD4 T cells were added to tissue culture plates coated 
with anti-CD3 along with soluble anti-CD28 for 72 hrs. After 72 hrs of stimulation, 
cells were rested for 48 hrs and then re-stimulated with PMA and ionomycin. 
Intracellular cytokine staining on these cells indicate that in PLD2 (-/-) mice, the 
CD4 T cells have 24% IL-2 positive cells compared to 5% (WT) and 12% 
(PLD2+/-) mice (Fig 35).  In contrast, the percentage of IL-4 secreting cells was 
lower in PLD2  (-/-) mice (6%) compared to WT (18%) and PLD2 (+/-) mice 
(12%).  We did not observe any significant differences in the cytokine levels of IL-
17 and TNF-α between WT and PLD2 (-/-) mice. Thus, the data indicate that  
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Fig 34. Characterization of CD4 T cell function in PLD2 deficient T cells. A)  
Activation markers, CD69 (y-axis) and CD25 (x-axis) following stimulation. Cells 
are gated on CD4 T cells after 24 hrs of stimulation with anti-CD3. B) 
Proliferation analysis of PLD2 deficient CD4 T cells after 72 hrs of stimulation 
with different concentrations of anti - CD3. WT, PLD2 (+/-) and PLD2 (-/-) mice 
are littermates. 
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Fig 35. Cytokine profiles of PLD2 deficient CD4 T cells. A) CD4 T cells from 
WT and PLD2 KO mice were stimulated with plate bound anti-CD3 and soluble 
CD28 for 72 hrs, following which cells were rested for 2 days. Cells were re-
stimulated with PMA and ionomycin and intracellular FACS staining for IL-2,  
IFN- γ, IL-4, IL-17 and TNF-α was performed. 
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PLD2 deficient CD4 T cells remain as IL-2 producers after three days of 
stimulation and have impairment in differentiation into Th2 type T cells. 
To test if PLD2 is necessary for effector T cell differentiation into different 
subsets namely Th1, Th2 or Th17, CD4 T cells from WT and PLD2 knock out 
mice were activated under Th1 (in the presence of IFN-γ, IL-12 and anti-IL-4), 
Th2 (in the presence of IL-4 and anti-IFN-γ) or Th17 (in the presence of TGF-β 
and IL-6) skewing conditions and FACS staining was performed to detect 
intracellular cytokine expression. Under Th1 induction conditions, 78% of WT 
CD4 T cells were IFN-γ positive and 11% were IL-2 positive while in PLD2 (-/-) 
mice 21% were IL-2 positive and 66% were IFN-γ positive (Fig 36, top row) 
indicating slight resistance to differentiate into Th1 phenotype. On the other 
hand, under Th2 induction conditions 1.8% of WT CD4 T cells were IL-4 positive 
in comparison to 0.8% of PLD2 (-/-) T cells (Fig 36, middle row). Under Th17 
skewing conditions, ~8% of CD4 T cells in PLD2 (-/-) mice were IL-17 positive 
compared to 6% of WT T cells (Fig 36, bottom row). Together, the data suggest 
that PLD2 (-/-) mice have slight impairment in differentiation into Th1/Th2 cell 
types and remain at IL-2 secreting stage. We can further assess effector T cell 
differentiation in PLD2 (-/-) mice in vivo (eg: by using P25 peptide, a strong 
inducer of Th1 response). 
In light of our previous findings, we next determined if ethanol/adenosine 
inhibits effector T cell proliferation through inhibiting PLD2. To test this, we 
treated WT, PLD2 (+/-) and PLD2 (-/-) mice with DMSO, A3 agonist or A3 agonist 
plus 0.5% ethanol. We predicted that if A3 agonist inhibited PLD2 signaling, then  
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Fig 36. Differentiation of PLD2 CD4 T cells into Th1, Th2 and Th17 Effector 
cells. Spleen CD4 T cells were stimulated with anti-CD3 in vitro and rested 5 
days in the presence of Th1, Th2 or Th17 skewing conditions. T cells were re-
stimulated with PMA and Ionomycin and intracellular cytokine staining was 
performed. 
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Fig 37. Effect of A3 receptor agonist on PLD2 deficient CD4 T cells. CD4 T 
cells isolated from WT and PLD2 KO mice spleen were stimulated with APC and 
anti-CD3 either in presence of A3 agonist (AB-MECA) or carrier control (DMSO) 
for 3 days. On day 4, cells were washed and placed in medium containing IL-2 
for 4 days. On day 7, cells were harvested and stained for detection of Foxp3 
expression and analyzed using flow cytometry. 
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Fig 38. Effect of ethanol on PLD2 deficient CD4 T cells. CD4 T cells isolated 
from WT and PLD2 KO mice spleen were stimulated with APC and anti-CD3  in 
the presence of varying concentrations of ethanol for 3 days. On day 4, cells 
were washed and placed in medium containing IL-2 for 4 days. On day 7, cells 
were harvested and stained for detection of Foxp3 expression and analyzed 
using flow cytometry. 
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treatment of PLD2 (+/-) with A3 agonist and ethanol would lead to increased 
frequency of Foxp3+ cells. However, we found no differences in the frequency of  
Foxp3+ cells between WT and PLD2 knock out mice under these treatment 
conditions (Fig 37 and 38). This suggests that A3 agonist/ethanol mediated 
enrichment of Treg cells might involve additional signaling pathways other than 
PLD2. Future experiments can be conducted to determine the level of PLD 
activity in PLD2 (-/-) T cells. Based on the experiments of Treg enrichment using 
AB-MECA/ethanol it is very likely that PLD1 compensates for the lack of PLD2 in 
PLD2 (-/-) mice thus exhibiting no difference in PLDactivity levels. 
Future studies in PLD2 (-/-) mice can be conducted to determine its role in 
T cell signaling and function. Previous data from the lab indicated that PLD2 is 
involved in proximal TCR signaling events. We can determine if PLD2 (-/-) mice 
exhibit altered TCR signaling pathway compared to WT mice.  
 
 
 
 
 
 
 
 
 
 
                                                                                                                                                 
CHAPTER FOUR 
DISCUSSION 
 
 
Introduction 
The response to pathogenic attack and maintenance of immune 
homeostasis requires precise coordination between different cell types of helper 
T cell subsets. Population balance between different types of cells is key to 
sustaining a balanced immune system. Many studies have reported altered 
balance between effector versus regulatory T cell subsets as the prime cause of 
disease pathogenesis. For instance, increased frequency and suppressor 
function of Treg cells have been reported and proposed as potential mechanism 
of immune suppression in patients with tumor and HIV-infection (Strauss et al., 
2007a) (Strauss et al., 2007b) (Sempere et al., 2007). On the other hand, 
reduced number/function of Treg cells and increased effector T cell function have 
been reported in patients with allergic/autoimmune diseases (Dejaco et al., 2006) 
(Bacchetta et al., 2006). 
Hence, ideal treatment for conditions of excessive immune suppression 
would be to enhance the frequency/ function of effector T cells and vice–versa for 
autoimmune diseases. Therapeutic potential of this strategy has spurred the
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interests of researchers leading to the discovery of many mechanisms for 
specific enrichment of either Treg cells or effector T cells.  
Previously, our lab reported the differential requirement for PLD signaling 
in Treg cells versus effector T cells. As a consequence, inhibition of PLD 
signaling led to preferential enrichment of Treg cells by inhibiting effector T cell 
proliferation. Interestingly, other reports suggest increased PLD expression and 
signaling in autoimmune myocarditis and chronic inflammation (Ahn et al., 2004). 
For my dissertation work, I focused on identification of mechanisms regulating 
PLD signaling in T cells. The data demonstrated that various exogenous 
(ethanol, bacterial toxins) and endogenous (adenosine) factors alter the immune 
balance through regulating PLD signaling. PLD2 deficient mice showed that the 
effect of these molecules on the Teff: Treg balance is not dependent on PLD2 
alone. Further the structure that controls the sub cellular localization of PLD1 and 
PLD2 was determined using mutant construct analysis. 
 
IMMUNE BALANCE: EFFECT OF EXOGENOUS FACTORS 
The human body is exposed to myriads of pathogens, pollutants, and 
environmental and bacterial toxins in day-to-day life. The immune system has 
evolved in many ways to combat these intruders and to maintain peace with self 
through mechanisms like plasticity of helper T cell subsets. But some pathogens 
and various exogenous molecules selectively manipulate the immune balance to 
their advantage by shifting the equilibrium between these activities one way or 
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the other. For instance, environmental toxin like dioxin has been shown to cause 
immune suppression by increasing Treg frequency (Quintana et al., 2008). Our 
data demonstrate that by inhibiting PLD signaling, exogenous factors like ethanol 
and C. difficile toxin tip the balance towards immune suppression. 
Our results suggest that these external factors by means of inhibiting PLD 
signaling, block the up regulation of activation induced CD25 expression on 
naïve CD4 T cells. IL-2 is an important T cell growth factor and CD25 is required 
for the proper function/signaling of IL-2. However, Treg cells constitutively 
express CD25 and thus expand in the presence of exogenous IL-2. The 
functional significance of ethanol/C. difficile toxin mediated inhibition of PLD 
signaling is suggested by the decreased proliferation of antigen specific effector 
T cells and increased frequency of antigen specific Treg cells in vivo. 
There is extensive evidence that ethanol consumption leads to immune 
suppression. Recently, both acute and chronic alcohol intake have been shown 
to result in specific defects in innate and adaptive immunity (Nelson and Kolls, 
2002). It is suggested that ethanol results in loss of splenic and circulating T and 
B cells through apoptosis (Shao et al., 1995) (Sibley and Jerrells, 2000). Our 
experiments using ethanol provide evidence to suggest that this loss of T cells 
might be due to lack of PLD signaling and its effect on naïve T cells. In addition 
to mediating its effect through CD4 T cells, alcohol has been shown to modulate 
the functioning of other immune cells like macrophages, neutrophils, dendritic 
cells with antigen presenting capabilities (Szabo et al., 1993) (Nelson and Kolls, 
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2002). The lack of activation induced marker expression on CD4 T cells might 
also be mediated through lack of antigen presentation through these APCs. 
Thus, in our experimental set up we cannot rule out the effect of ethanol on these 
APCs and the consequent reduction in TCR activation and PLD signaling. 
In contrast to mice injected with ethanol intraperitoneally, mice fed on 
alcohol diet showed increased frequency of Treg cells only locally (mesenteric 
lymph nodes). This result can be explained based on previous studies 
suggesting that oral administration of ethanol results in increased availability and 
metabolism of ethanol in the gut resulting in less entry of ethanol into the blood 
stream while intraperitoneal injections result in rapid appearance of ethanol in the 
blood stream (Livy et al., 2003). Thus oral exposure of alcohol reflects the 
localized effect of ethanol on T cells while intraperitoneal injection reflects 
systemic effect of ethanol on T cells. This phenomenon of local immune 
suppression could in principle be exploited for treatment of gut associated 
inflammatory diseases like IBD and colitis. 
Our studies with C. difficile toxin demonstrate a new facet of immune 
evasion strategy through PLD signaling. C. difficile toxins have long been known 
to induce reorganization of actin filaments due to modification of Rho proteins 
(Ottlinger and Lin, 1988). Since PLD is an effector molecule of Rho, C. difficile 
was also reported to inhibit PLD signaling. However, functional relevance for the 
lack of PLD signaling was not previously established. On the basis of our 
experimental results, we propose that by inhibiting PLD signaling in naïve T cells 
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through toxin B, C. difficile eliminates effector T cell functions. The consequent 
increase in the frequency of Treg cells aids the pathogen’s success in promoting 
illness and furthering its own survival. Although we report the effect of Toxin B on 
altering the immune balance, we have not tested the effect of blocking Toxin B 
using anti-Toxin B antibodies. Based on our results, we predict that blocking of 
Toxin B would mitigate the effects of C. difficile on the immune system and 
ameliorate the disease progression by promoting effector and memory T cell 
expansion. 
 
IMMUNE BALANCE: EFFECT OF ENDOGENOUS FACTORS 
One of the drawbacks of a powerful immune response is uncontrolled immune 
response against pathogens and associated collateral damage to self. The 
restraint of uncontrolled immune response is mediated through negative feed 
back mechanisms. Adenosine (Ado) is an endogenous molecule well known for 
its role in mediating the negative feed back mechanisms of immune responses. 
Previous studies have reported inhibition of inflammation following activation of 
adenosine receptors. Adenosine receptors are expressed by all immune cells 
and A2a receptor signaling on macrophages, dendritic cells and T cells have 
been shown to inhibit effector function (Zarek et al., 2008). Based on many 
studies, A2a receptors are considered the dominant receptor dictating 
lymphocyte responses in T cells. 
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 Here we demonstrate the role of A3 receptor in inhibiting effector T cell 
responses. The data indicate that stimulation of T cells in the presence of A3 
receptor agonist inhibits TCR induced activation of PLD signaling. This inhibition 
of PLD signaling abrogates CD25 expression, effector T cell proliferation, and 
cytokine secretion. Although, signaling through A3 receptor in other immune cells 
results in low cAMP concentrations, we found that signaling through A3 receptor 
in CD4 T cells results in elevated cAMP levels and increased PKA activity. 
Previous studies on A3 receptors report both pro and anti-inflammatory 
effects depending on the system investigated (mast cells, macrophages) and 
species examined (rat, humans) etc (Gessi et al., 2008).  However, the specific 
effect of activating A3 receptors on CD4 T cells has never been studied. In the 
heart, A3 receptors mediate cardioprotection through modulating PLD signaling 
(Mozzicato et al., 2004). This led us to determine the effect of A3 receptor 
signaling on CD4 T cells. We found that A3 receptor signaling blocked TCR 
induced PLD activation. At present, we do not know the exact mechanism of A3 
receptor signaling leading to PLD signal inhibition. Inhibition of PLD by A2a 
receptors is mediated by interference with the translocation of small GTPases, 
Arf and Rho (Thibault et al., 2000). In future, we can test if A3 receptor inhibits 
PLD through translocation of small GTPases as well. One recent study also 
demonstrated inhibition of PLD1 activity directly by Gβγ subunits (Preininger et 
al., 2006). 
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Since adenosine receptors are coupled to G-protein, signaling is thought 
to occur either through the inhibition or stimulation of adenylyl cyclase resulting in 
a decrease or increase of intracellular cAMP concentration respectively. The 
classical signaling pathway associated with A3 receptor suggests Gi mediated 
inhibition of adenylyl cyclase with a concomitant decrease in cAMP 
concentrations. We experimentally determined the effect of A3 receptor 
activation on cAMP concentrations. Contrary to previous reports, we found 
increased cAMP levels in A3 receptor agonist treated CD4 Tcells. This increased 
cAMP levels also resulted in increased PKA activity. The effect of A3 receptor 
activation on inhibition of effector T cell proliferation and concomitant increase in 
Treg frequency was indeed reproducible by the cell permeable analog of cAMP, 
db-cAMP. Future experiments can be done to determine if the effect of A3 
receptor is solely mediated by cAMP and PKA by co-culturing CD4 T cells with 
A3R agonist and PKA inhibitor H-89. 
A3 receptor is coupled to trimeric GTP binding proteins, Gαi and/or Gαo 
and Gβγ dimers. The αi subunits directly inhibit adenylyl cyclase. However βγ 
dimers from Gi/o are known to activate adenylyl cyclase (AC) isozymes II and IV 
(Yao et al., 2002). We speculate that the increase in cAMP levels caused by A3R 
activation is mediated through βγ dimers. We can test if this is indeed the case by 
inhibiting βγ signaling. One way to inhibit βγ signaling is through over expression 
of the carboxyl terminal of βARK1 retrovirally in CD4 T cells. Previous evidence 
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suggests that expression of carboxyl terminus of βARK1 binds free βγ dimers and 
thus inhibits βγ signaling (Yao et al., 2002) (Koch et al., 1994). 
 Depending on the cell type studied, cAMP has been reported to inhibit (Le 
Stunff et al., 2000; Thibault et al., 2002) or activate (Mamoon et al., 1999) PLD 
activity  through PKA signaling.  In our experiments, we detected increased 
cAMP levels in CD4 T cells treated with A3R agonist 5 mins following T cell 
stimulation and observed a decrease in the PLD activity 15-30 mins after TCR 
stimulation. Based on these results, it is very likely that increased cAMP levels 
caused by A3 receptor signaling results in inhibition of PLD signaling. The 
experiment using inhibitor of PKA (H-89) and/or constitutively active form of PKA 
could also be used to determine PLD activity following PKA signaling.  
Based on our various observations, we propose the following model 
depicting A3 receptor signaling in CD4 T cells (Fig 39). Two different pathways 
can mediate the effect of A3 receptor signaling in T cells. A central role for Gi/o 
βγ is proposed. A3 receptor activation can lead to increased cAMP levels and 
PKA signaling. PKA has been demonstrated to inhibit PLD activation. Another 
possibility is βγ dimers can directly inhibit PLD activity (Preininger et al., 2006). 
 The ability of A3 receptor agonist to promote regulatory T cell enrichment 
in vivo suggests that it could be used for treatment of autoimmune diseases. 
Studies in mice and rats demonstrate that the anti-inflammatory effects of 
methotrexate are in part mediated via A3 receptors (Montesinos et al., 2003). 
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Perhaps, methotrexate acting through A3 receptor on CD4 T cells blocks PLD 
signaling and leads to Treg enrichment.  
Interestingly, it has been demonstrated that A3 receptor is over expressed 
in cancer tissues in comparison to normal tissues (Gessi et al., 2004a). It should 
be noted that the concentration of adenosine in solid tumor reaches as high as 
100μM due to high levels of hypoxia (Hasko and Cronstein, 2004). Thus, it is 
highly likely that T cells activated by MHC class II positive APCs in these tissues 
are selectively blocked via A3 receptor signaling. Moreover, since A3 receptor 
agonists inhibit IFN-γ secretion, A3 receptor antagonists could be effective in 
tumor immunotherapy. 
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Fig 39. Schematic representation of A3 receptor signaling in CD4 T cells. A 
central role for Gi/o βγ subunits is proposed. A3 receptor activation leads to 
increased cAMP levels and activates PKA. PKA has been demonstrated to inhibit 
PLD activation. Another possibility is βγ dimers directly inhibit PLD activity 
(Preininger et al., 2006). 
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AB-MECA AND ETHANOL: POTENTIAL USE AS A TOLEROGENIC 
ADJUVANT 
 
Our data show that concurrent presence of PLD suppressive factors such 
as adenosine and ethanol impose substantial suppression of immune response. 
We observed that 0.5% ethanol had no effect of inhibition of effector T cell 
proliferation or expansion of Treg cells. However, combination of 0.5% ethanol 
with A3 receptor agonist led to substantial decrease in effector T cell 
proliferation. This suggests that there exists a threshold for PLD activity in T cells 
and the combination of ethanol and AB-MECA pushes PLD activity well below 
this threshold. Under these conditions, we see a sizable effect of PLD inhibition 
on effector T cell proliferation and subsequent enrichment of Treg cells.  
A very high concentration of ethanol leads to cell death due to the toxic 
effects of by products of ethanol (Lieber, 1997). However, we can avoid these 
toxic effects by using a combination of low doses of ethanol and AB-MECA.   
Induction/expansion of antigen-specific Treg cells is of great therapeutic 
interest for the treatment of autoimmunity, allergy and organ transplantation. Our 
studies using AB-MECA/ethanol show expansion of antigen specific Treg cells in 
vivo. Therefore, AB-MECA alone or combination of AB-MECA and low dose 
ethanol may be used in immunotherapy of various diseases. 
A recent study proposed the use of immunosuppressants like 
dexamethasone (DEX) as tolerogenic adjuvants (Kang et al., 2008). They 
demonstrated that antigenic immunization combined with DEX led to block of 
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dendritic cell (DC) maturation and preferential expansion of antigen specific 
Foxp3+ cells. Based on the similar effect observed with AB-MECA /ethanol, we 
propose that agents inhibiting PLD signaling can be used as tolerogenic 
adjuvants. However, we do not know the effect of AB-MECA and ethanol on the 
status of DC maturation. Future experiments can be designed to evaluate the 
effect of PLD signaling in antigen presenting cells like DC. 
 
PLD LOCALIZATION: INTERACTION BETWEEN MULTIPLE STRUCTURES 
PLD1 and PLD2 are 50% identical and display similar domain structures. 
However, they localize to different regions in the cell. It is suggested that 
localization determines intermolecular interaction with downstream target 
molecules thus serving different functions in signal transduction. A previous 
report shows that deletion of the loop region in PLD1 led to an increase in its 
basal activity levels but the localization of the loop deletion mutant was not 
determined. We over expressed loop deletion mutant in the Jurkat T cell line and 
found that it had plasma membrane localization similar to PLD2. Since PLD2 is 
characterized by high basal activity it is very likely that the increased activity of 
the loop deletion mutant is in part due to its plasma membrane localization and 
potential modification by membrane attached enzymes (eg: phosphorylation). 
 A puzzling observation was that the isolated loop domain had plasma 
membrane localization as well. Since deletion of loop from PLD1 abrogates its 
distribution from vesicular structures we hypothesize that the coordinated 
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interaction of loop within PLD1 and with unknown structure in the cell sequesters 
it to vesicular structures. One way to test this hypothesis is to insert the isolated 
loop domain into full length PLD2. If the interaction of loop with the other domains 
is the factor governing its vesicular localization, then PLD2 will localize similar to 
PLD1. 
 A previous report suggests that PH, PX and palmitoylation sites on the N-
terminal region of PLD1 serve as potential membrane binding determinants 
(Sugars et al., 2002). In agreement with previous studies, in a deletion mutant 
encompassing all 3 potential sites (N-terminal deletion mutant), the membrane 
binding determinants redistributed to the cytoplasm. We also tested the cellular 
distribution of the isolated ‘PH+PX’ domain of PLD1. The localization of this 
mutant did not resemble that of full length PLD1. Rather it was found to have a 
diffuse localization in both cytoplasm and nucleus similar to vector construct. 
Based on this result, we suggest that  ‘PH+PX’ domain cannot be studied in 
isolation. Other studies suggest that an intact C-terminus of PLD1 is required for 
its function (Liu et al., 2001). We made a deletion mutant containing the C-
terminus fused with YFP. Interestingly, this mutant localized only in the nucleus 
of the cell. Taken together, we propose that a single domain does not determine 
the localization of PLD1. Rather interactions between different domains of PLD1 
and with other cellular components regulate localization of PLD1 in sub cellular 
structures. The presence of C-terminal region alone determines its nuclear 
localization while interaction of the C-terminal region with catalytic domains and 
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the loop region redistributes PLD1 to the cytoplasm. Further, the interaction of N-
terminal domains (PX+PH) with the rest of PLD1 determines its localization in 
membranous vesicles like golgi. 
We undertook experiments to determine the domains necessary for the 
plasma membrane localization of PLD2. As proposed for PLD1, similar 
interaction between domains determines its plasma membrane localization.  
Isolated C-terminus mutant of PLD2 had nuclear localization while the mutant 
with the presence of PH+PX along with the C-terminus redistributed to the 
cytoplasm. Further, the interaction of the region containing the catalytic domains 
with the rest of PLD2 results in its plasma membrane localization. Our studies 
provide evidence for the role of different domains of PLD1 and PLD2 in 
determining their respective localizations under basal condition. Future 
experiments can be conducted to determine the cellular binding target of PLD 
proteins particularly the loop and N-terminal half. It is possible that various 
modifications of typical residues mediate the hierarchy of localization signals. 
This can be addressed using a site directed mutagenesis approach. Also, we 
have not examined the functional effect of these mutations. Functional studies in 
future will provide a better understanding of the role of localization in determining 
specific functions. 
 
PLD2 AND T CELL FUNCTIONING 
 
As a result of the critical role of PLD in development, PLD null mutants are 
embryonic lethal (LaLonde et al., 2006). In PLD2flox/flox CD4 cre mice, PLD2 is 
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deleted relatively late (double positive stage).  Our data demonstrate that PLD2 
is dispensable for T cell development after the double positive stage of 
thymocyte differentiation. Our data does not address the role of PLD2 in earlier 
aspects of T cell development.  
Also, deficiency of PLD2 did not affect CD4 T cell activation and 
proliferation. On the other hand, we did observe differences in cytokine secretion 
profiles of PLD2 deficient T cells. PLD2 deficient T cell cultures had more IL-2 
positive cells than wild type T cells and showed resistance to differentiate in to 
Th1 and Th2 lineage in vitro. This effect on effector T cell differentiation might be 
caused by blockade of transcription factors like T-bet and GATA3. These 
possibilities can be investigated in the future. 
Surprisingly, PLD2 deletion had very little effect, if any, on the expansion 
of regulatory T cells. One possible explanation is that PLD1 compensates for the 
lack of PLD2.  We can test for this possibility by inducibly deleting PLD1 alone in 
PLD2 CD4 cre knock out mice. Another possibility is that PLD2 deficient T cells 
are inherently different due to their thymocyte development and differentiation in 
the absence of PLD2 signals. The other exciting possibility is perhaps that PLD2 
is more important under conditions of physiological stress. This possibility can be 
addressed by inducing autoimmunity or by observing the immunological 
response to pathogens in PLD2 deficient mice in vivo. Nonetheless, these 
experiments in PLD2 knock out mice have brought to light previously unknown 
questions and answers. 
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CONCLUDING REMARKS 
PLD signaling in T cells was discovered in 1991. However, until now the 
specific role of PA and PLD in T cell functioning has not been clear. Our lab 
group was the first to highlight the differential requirement of PLD signaling in 
effector versus regulatory T cells. This led us to investigate the role of PLD 
signaling in T cells. My dissertation work has focused on identifying the 
regulation of PLD signaling in T cells. I found that physiological molecules like 
adenosine maintain immune homeostasis by modulating PLD signaling. In 
addition, I discovered that pathogens/ exogenous molecules could alter the host 
immune response by virtue of their PLD inhibiting properties. Further, I 
determined the structure that controls the sub-cellular localization of PLD 
isoforms and their specific role in T cell function. These studies highlight the 
complex array of functions mediated by PLD in T cells. In the process of studying 
PLD, we have also discovered the role of adenosine A3 receptor signaling in T 
cells. This study highlights the role of crosstalk between different signaling 
pathways in human health and disease.
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